Acute myocardial infarction patient data to assess healthcare utilization and treatments. by Ramos, Pedro
University of Louisville 
ThinkIR: The University of Louisville's Institutional Repository 
Electronic Theses and Dissertations 
12-2011 
Acute myocardial infarction patient data to assess healthcare 
utilization and treatments. 
Pedro Ramos 
University of Louisville 
Follow this and additional works at: https://ir.library.louisville.edu/etd 
Recommended Citation 
Ramos, Pedro, "Acute myocardial infarction patient data to assess healthcare utilization and treatments." 
(2011). Electronic Theses and Dissertations. Paper 1178. 
https://doi.org/10.18297/etd/1178 
This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's 
Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized 
administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the 
author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu. 
ACUTE MYOCARDIAL INFARCTION PATIENT DATA TO ASSESS 
HEAL THCARE UTILIZATION AND TREATMENTS 
By 
Pedro Ramos 
B.S. Delta State University, 1999 
M.S. Middle Tennessee State University, 2005 
A Dissertation 
Submitted to the Faculty of the 
College of Arts and Sciences of the University of Louisville 
in Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy 
Department of Mathematics 
University of Louisville 
Louisville, Kentucky 
December 2011 
MINING ACUTE MYOCARDIAL INFARCTION PATIENT DATA TO ASSESS 
HEALTHCARE UTILIZATION AND TREATMENTS 
By 
Pedro Ramos 
B.S. Delta State University, 1999 
M.S. Middle Tennessee State University, 2005 
A dissertation approved on 
November 18, 2011 
By the following Dissertation Committee 
Dr. Patricia Cerrito (Director) 
Dr. RYan Gill (Co-Director) 
'or. Jiaxu Li 
D.r. Ibrahim Imam 
Dr. Thomas Riedel 
ii 
ABSTRACT 
MINING ACUTE MYOCARDIAL INFARCTION PATIENT DATA TO ASSESS 
HEAL THCARE UTILIZATION AND TREATMENTS 
Pedro Ramos 
November 18, 2011 
The goal of this study is to use a data mining framework to assess the 
three main treatments for acute myocardial infarction: thrombolytic therapy, 
percutaneous coronary intervention (percutaneous angioplasty), and coronary 
artery bypass surgery. The need for a data mining framework in this study arises 
because of the use of real world data rather than highly clean and homogenous 
data found in most clinical trials and epidemiological studies. The assessment is 
based on determining a profile of patients undergoing an episode of acute 
myocardial infarction, determine resource utilization by treatment, and creating a 
model that predicts each treatment resource utilization and cost. 
Text Mining is used to find a subset of input attributes that characterize 
subjects who undergo the different treatments for acute myocardial infarction as 
well as distinct resource utilization profiles. Classical statistical methods are 
used to evaluate the results of text clustering. The features selected by 
supervised learning are used to build predictive models for resource utilization 
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and are compared with those features selected by traditional statistical methods 
for a predictive model with the same outcome. Sequence analysis is used to 
determine the sequence of treatment of acute myocardial infarction. The 
resulting sequence is used to construct a probability tree that defines the basis 
for cost effectiveness analysis that compares acute myocardial infarction 
treatments. To determine effectiveness, survival analysis methodology is 
implemented to assess the occurrence of death during the hospitalization, the 
likelihood of a repeated episode of acute myocardial infarction, and the length of 
time between reoccurrence of an episode of acute myocardial infarction or the 
occurrence of death. 
The complexity of this study was mainly based on the data source used: 
administrative data from insurance claims. Such data source was not originally 
designed for the study of health outcomes or health resource utilization. 
However, by transforming record tables from many-to-many relations to one-to-
one relations, they became useful in tracking the evolution of disease and 
disease outcomes. Also, by transforming tables from a wide-format to a long-
format, the records became analyzable by many data mining algorithms. 
Moreover, this study contributed to field of applied mathematics and public health 
by implementing a sequence analysis on consecutive procedures to determine 
the sequence of events that describe the evolution of a hospitalization for acute 
myocardial infarction. This same data transformation and algorithm can be used 
in the study of rare diseases whose evolution is not well understood. 
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This study has the objective of investigating the various treatments for 
emergent myocardial infarction based on claims databases. During the 
treatment of emergent myocardial infarction, different procedures are required to 
stabilize the patient, and these procedures have various outcomes associated 
with them. Part of this investigation examines the sequence of procedures 
involved in the treatment of myocardial infarction and their corresponding 
outcomes. In addition, lots of variability exists in the cost of treatment of 
emergent myocardial infarction; this dissertation aims to build cost predictive 
models and resource utilization models of acceptable accuracy. Since various 
treatments have been developed and perfected in the past decade, the 
effectiveness of these treatments will be assessed. To comprehensively study 
these treatments, an economic evaluation thereof will be conducted in the form of 
a cost-effectiveness analysis. 
Claims databases and patient registries can be considered retrospective 
observational studies with content about a patient's health conditions, particular 
disease, and receipt of a particular treatment. They can be used for 
understanding natural history, assessing quality of care, provider performance, 
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and assessing cost-effectiveness. Claims databases involve a diverse group of 
patients in contrast to clinical trials that seek uniformity in the participating 
subjects. Therefore, these databases better reflect real-world management 
practices and outcomes than randomized control trials. Indeed, their information 
can build on clinical trial data to update decision models and cost-effectiveness 
models to provide a more realistic picture of a method/intervention/product's 
value. 
Whereas clear guidelines to conduct, analyze, and report on clinical trials 
and cohort studies exist, similar guidelines to design and conduct studies based 
on registries and claims databases have not been developed. Without the 
structure of a clinical trial or cohort protocol, a daunting number of challenges to 
analyze and assess real-world data remains. For one, clinical trials descriptive 
analyses are based on standard assessment tools and fixed assessment times, 
and rely on randomization to allow group comparisons free of bias due to patient 
selection and other factors. Cohort studies, which capture time related changes, 
predetermine a fixed set of confounders to be measured in order to adjust the 
causal-effect analysis and control for bias. However, these methodologies fail to 
capture the complexity of the evolving real world and confounders that are not 
considered in the analysis. Dynamically complex problems often involve long 
delays between cause and effect as well as multiple goals and interests that may 
conflict, in various ways, with each other. Although such methods are successful 
in some areas of the health enterprise in the United States - and the world -
they are confined to solving a problem without fully considering spilling effects. 
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In other words, this approach addresses problems in a piece-meal fashion. A 
short excerpt of Utopia by Sir Thomas More better describes this situation 
concisely [1]: 
"By applying one remedy to one sore, you will provoke 
another; and that which removes the one ill symptom produces 
others, whereas the strengthening one part weakens the rest. " 
In this dissertation, I propose a data mining framework, in the analysis of 
claims databases that encompasses knowledge discovery, inference, and 
prediction to develop decision models to guide private and public health policy 
decision makers. To empirically examine their feasibility, claims databases will 
be examined with respect to outcomes, resource utilization, cost of illness, and 
disparities in myocardial infarction patients. 
First, classical methods such as literature reviews and possible meta-
analysis techniques should be considered in the exploratory phase in order to 
account for known confounders and avoid reinventing the wheel. In addition, 
exploratory data mining methods should be implemented to determine unknown 
confounders and possibly new outcomes. If possible, linkage among disparate 
databases should be implemented. Secondly, if temporal information is found in 
the database, this should be explored and analyzed to account for risk factors, 
diseases, and health resources that are in a continuous state of interaction and 
continuous change. Similarly, spatial features, if available, should be data mined 
to understand the space-dependency of the various confounders. This should be 
followed by the construction of influential diagrams that incorporate time and 
space. Data modeling and simulation should be used to incorporate robustness 
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in inference and to implement a what-if analysis that is able to reproduce 
historical patterns, but also able to generate insights. To explore possible 
futures, predictive modeling is paramount. Diagnostics, sensibility analysis, and 
performance measurements must be conducted. 
Myocardial Infarction 
The heart is the most active muscle in the body and needs a constant 
supply of blood, which the cardiac conducting system controls by transporting 
electrical impulses through the cardiac muscle to trigger a series of contractions 
[2]. The impulse of each heartbeat starts in the sinoatrial node, and it flows 
quickly through the atria and causes them to contract - atrial systole. Electricity 
does not pass directly between the atria and ventricles; instead, it is channeled 
into the atrioventricular node where it is delayed slightly. This ensures that the 
atrial contraction has finished before the ventricles start to contract. Although the 
heart chambers are always full of blood, the blood cannot reach all of the cells of 
its walls, so the heart has its own blood vessels, the coronary circulation. The 
coronary arteries that supply the heart are forced to close under the pressure of 
the contracting muscle. They therefore can only fill when the heart is relaxed 
during diastole. 
A heart attack or myocardial infarction (MI) occurs when blood supply to 
the heart is disrupted by an occlusion in one or more of the coronary arteries. 
This deprivation of blood to the heart muscle causes damage or possibly death to 
the heart's tissues known as myocardium [3].lt is been well established that the 
longer the heart is deprived of blood, more of the heart muscle is damaged and 
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killed. The axiom cardiologists have is that time saved is heart saved and thus 
establishing the need to open the coronary arteries occluded as quickly as 
possible [4]. 
Some of the symptoms of a heart attack are chest pain or angina, 
shortness of breath, profuse sweating, a burning sensation in the esophagus, 
and radiating pain to the arms and legs, especially on the left side of the body. 
Individuals who have previously been diagnosed with angina pectoris are aware 
of these symptoms and know that they must manage the pain with nitroglycerin 
and aspirin [4-6]. For this group of individuals, it is not recommended that they 
seek medical attention unless the pain does not subside within five minutes. If 
this is the case, then the individuals should visit an emergency department to 
alleviate pain and to receive treatment. 
STEMI 
One of the least predictable and most severe heart attacks is classified as 
ST, elevated myocardial infarction (STEMI). It is caused by sudden clots, known 
as thrombotic occlusions, in the coronary arteries that had not experienced any 
narrowing previously [7]. They are indicated by the electrocardiogram (ECG), 
which is performed upon admission to the emergency department, when the 
ECG displays an abnormal elevation in the liST segment" of the electrical heart 
wave. STEMI is considered the most severe type of heart attack because it is 
caused by a complete occlusion of one of the coronary arteries. The less blood 
that flows into the heart and the longer the diminished flow lasts, the greater the 
damage to the heart muscle (myocardium) and the less likely the patient will 
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recuperate. For individual who have not had a history of angina pectoris, it is 
essential that they seek medical attention as the maxim cardiologists follow is 
that time saved is heart saved. 
Diagnosis of a MI 
Once a patient is at the emergency department, emergency personnel will 
follow a well established and studied algorithm to determine if the individual is 
experiencing an MI. Nonetheless, emergency departments routinely begin 
treatment for an MI, believing a false-positive (treating an MI while the patient 
truly has, for example, heart burn) is a less severe mistake to make than a false-
negative (treat for heart burn while the patient is experiencing an MI) [8]. The 
patient (and/or their relatives) will be asked several questions concerning the 
patient's medical history to determine the risk of a heart attack. In addition, a 
series of diagnostic tests will be conducted immediately upon arrival to the 
hospital: electrocardiogram, blood test, and echocardiogram. The 
electrocardiogram (ECG) and echocardiogram (ECHO) are usually performed in 
tandem. During an electrocardiogram, electrodes are positioned on the chest 
and limbs in ~uch a way that electrical currents in all areas of the heart can be 
monitored. The recording displays the voltage between pairs of electrodes. In a 
typical ECG, each heartbeat produces three distinctive waves, P, QRS, and T 
that show a regular beat. Electrical activity in the sinoatrial node instigates atrial 
systole. The P-wave represents the spreading of electrical impulses from the 
sinoatrial node, through the atria, to the atrioventricular node. Then, electrical 
activity, represented by the QRS-wave, continues from the atrioventricular node 
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through the ventricles to produce ventricular contraction. Finally, the electrical 
impulse recedes as the heart resets itself, represented by T -wave, and both the 
atria and ventricles relax completely. 
The ECG can also identify the site of any damage that disturbs the flow of 
electricity, as the waves will form an unusual pattern. While an electrocardiogram 
assesses the electrical activity of the heart, an echocardiogram uses ultrasound 
to produce images of the heart structures. The benefits of these tests will be 
discussed below, but the results of these tests allow cardiologists to determine 
the exact type of MI a patient is experiencing (e.g., STEMI). The most definitive 
test to establish if an MI is occurring is the confirmatory blood tests. The human 
body only produces changes in the levels of the enzymes, troponin and creatine 
kinase, if the heart muscle has recently been damaged. Therefore, if these 
enzymes show in the blood test, it is a very definitive indication that an MI has 
occurred [8]. There are many reasons for the presence of creatine kinase, 
including kidney failure. Troponin type Tnl and type TnT are produced ONLY in 
the heart. They are normally present in the blood. When a heart attack occurs, 
their levels spike within three hours. They tend to remained elevated for several 
days thereafter: 
• Type 1: spontaneous and related to ischemia due to a coronary event. 
• Type 2: secondary to ischemia due to an imbalance between oxygen 
demand and supply. 
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• Type 3: sudden cardiac death with symptoms of ischemia and new ST 
elevation or LBBD, verified thrombus by angiography, or autopsy. 
• Type 4a: associated with previously performed PCI. 
• Type 4b: associated with verified stent thrombosis. 
• Type 5: associated with CABG. 
However, for practical purposes, and in clinical settings, an MI is classified 
based on results from an electrocardiographic diagnostic test that assesses the 
heart's various electrical waves to determine the precise site of the infarction[6, 
9]: 
• Inferior (or diaphragmatic) wall: II, II and aVF 
• Septal: V1 and V2 
• Anteroseptal: V1, V2, Vf3 and sometimes V4 
• Anterior: V3, V4 and sometimes V2 
• Apical: V3, V4 or both 
• Lateral: I, aVL, V5 and V6 
• Extensive anterior: I, aVL and V1 through V6 
According to the ECG reading, the severity of the MI can also be 
determined as either STEMI, the most severe, or NSTEMI [4]. STEMI will display 
an elevation in the ST segment of the T-wave, which represents a total occlusion 
of a coronary artery. 
Treatment of STEMI 
Currently, there are three options to treat patients experiencing a STEMI 
heart attack: thrombolysis, percutaneous coronary intervention (PCI), also known 
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as balloon angioplasty, and coronary artery bypass graft surgery (CABG) if three 
or more occlusions have occurred [5-7]. 
Thrombolysis consists of injecting the patient with clot-diluting drugs in 
order to open the blocked artery. However, thrombolysis has been considered a 
less effective and less efficacious reperfusion technique since it takes an 
extended amount of time to begin to work [5, 10]. By the time thrombolysis 
dilutes the clot, too much of the myocardium is dead or damaged severely. 
Thrombolysis was the first strategy developed to combat occlusions. However, 
more recently, PCI has been repeatedly shown in numerous differing populations 
to be more effective and efficacious when compared with thrombolysis, in 
preserving more of a patient's myocardium. PCI has shown to have superior 
clinical outcomes such as lower mortality rates, lower rates of recurrence of 
thrombotic occlusion, lower rates of re-infarction, and shorter recovery times to a 
productive life [7, 11-14]. The evidence on cost-effectiveness of thrombolysis 
versus angioplasty has not been conclusive. A study by Hartwell et al. favored 
percutaneous coronary intervention over thrombolysis. However, a study 
conducted by Reeder et al in 1994 concluded that these alternatives are equally 
cost-effective. 
Development of Thrombolytic Therapy 
Thrombolytic or fibrinolytic therapy was originally studied and developed in 
the 1950's with promising results by Dr. Sol Sherry who demonstrated that 
streptokinase could dissolve blood clots that typically occluded coronary arteries. 
However, more recent reperfusion theory demonstrates that thrombosis is a 
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secondary event in ischemic events. Long after the advance that a coronary 
occlusion was an etiology of acute myocardial infarction, the Gruppo Italiano per 
10 Studio della Streptochinasi nell'lnfarctomiocardio (GISSI) study (in 1986) 
established through a multicenter randomized clinical trial that in-hospital 
mortality was reduced by more than 3% following streptokinase administration 
[5]. Yet, streptokinase and other first generation thrombolytic agents came with 
the limitation of being immunogenic and a third of the patients receiving therapy 
were unresponsive to such therapy. 
DNA research advances led to fibrin specific plasminogen activators, 
which resulted in much lower rates of mortality and risk reduction when 
compared to streptokinase to treat AMI leading to extended hope for 
thrombolysis. Similarly, aspirin demonstrated similar survival benefits to those of 
streptokinase alone in several clinical trials. The use of these drugs have 
become part of the American College of Cardiology/American Heart Association 
guidelines for the treatment of MI as evidence based quality of care measures; 
however, no study has been conducted in the cost-effectiveness thereof [10]. 
Percutaneous Coronary Intervention 
PCI, or angioplasty, was developed in 1977 when the Swiss radiologist, 
Andreas Gruentzig, performed the first percutaneous transluminal coronary 
angioplasty on a thirty-eight year old patient with a left coronary artery lesion [15]. 
Compared to today's equipment, the catheters were large and could easily injure 
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a blood vessel. In addition, no guidewires were used and balloon catheters 
would discharge suddenly at low-pressure levels, which rendered this type of 
intervention available to only ten percent of patients needing revascularization. 
Fortunately, during the early 1980s, the catheters were manufactured to a 
smaller diameter and balloons were designed to inflate at higher pressures, 
which made balloon angioplasty available to nearly 50% of patients in need of 
revascularization. However, one of the drawbacks of balloon angioplasty is that 
it fractures plaque that is causing the current occlusion. The fissured atheroma 
may cause the formation of a new thrombus later. Another limitation is the 
weakening of the vessel that may cause the vessel to recoil, resulting in 
restenosis. As a result, new devices aimed to combat these limitations were 
developed and manufactured. The transluminal extraction catheter and excimer 
laser enabled the development of atherectomy, although they were not 
associated with a reduction in the incidence of restenosis, rendering these 
instruments as niche tools. It was not until the advent of coronary stents in 1986 
that PCI was shown to be safe and more effective by significantly reducing 
restenosis. Improvements to stents such as pharmacologic coating and various 
levels of flexibility and strength followed in the 1990s and the first decade of the 
twenty-first century. 
PCI (emergency angioplasty) is performed in a series of steps with slight 
variations for an individual case. Once the patient presents at the emergency 
facility, the patient is treated with a fibrinolytic agent unless contraindicated by 
the patient's clinical condition such as ventricular arrhythmias or cardiogenic 
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shock[4, 5, 10, 15, 16]. Subsequently and immediately, an angiogram is 
performed. During an angiogram, a catheter is inserted into one of the femoral 
arteries (located in the groin/thigh) and guided to the coronary arteries. The 
femoral arteries are the largest arteries in the body. Injuries to the femoral artery 
used can result very rapidly in severe blood loss and possible death and thus 
creating the need for PCI's to be performed by experienced surgeons, well-
staffed and experienced catheter labs, and at well-equipped facilities. A 
contrasting substance is then injected into the vessel to make the area 
surrounding the heart clear in the X-ray images. It is this tool that allows the 
emergency personnel to determine what vessels are blocked. After the affected 
area has been determined, a balloon catheter is inserted and guided to the 
blocked vessel. Once in place, the balloon is inflated to open out the walls of the 
blood vessel and crush the clot. Also, it is recommended to place a tubular 
mesh, know as a stent, in the affected segment of the blood vessel to prevent the 
collapse of the vessel's walls. Finally, the catheter is removed and the entry-
puncture sealed or the catheter may be left in place up to twelve hours, 
depending on the length of time needed to prevent the patient's blood from 
thinning with further complication of severe hemorrhage or death. After 
successful angioplasty, most patients are discharged within 24 hours of the 
procedure. 
One key aspect necessary for PCI to be successful is the door-to-balloon 
time (OTB )[16-21]. This is the length of time between the patient arriving at the 
emergency facility and the moment the balloon is inflated in the affected segment 
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of a blood vessel. After many clinical studies, it has been determined that the 
DTB should be less than 90 minutes. The reason for this timeframe is that it 
provided, in multiple clinical trials, lower in-hospital death rates, reduced 30-day 
mortality rates, shorter average lengths of stay in the hospital, lower rates of re-
infarction, and lower rates of re-occlusion[17, 19, 21-23]. 
Effectiveness of PCI 
Several clinical trials have been conducted to investigate the effectiveness 
of PCI compared to adjunctive therapy in NSTEMI patients. A key idea in these 
results was the stratification of the patients according to the Thrombolysis 
Myocardial Infarction (TIMI) score, which classifies patients as high, medium, or 
low risk. High-risk patients, with TIMI scores of five or greater, are those with 
three or more of the following characteristics: prolonged chest pain, hypotension, 
65-years of age or older, ST -segment changes, and elevated biomarkers levels 
[2]. 
Retrospective studies based on the Global Registry of Acute Coronary 
Events (GRACE) and the Euro Heart Survey of Acute Coronary Syndromes 
found that the proportion of patients with an admission diagnosis of unstable 
angina or MI quickly progress to NSTEMI (24% and 21 % respectively) or to 
STEMI (6% and 69% respectively) [16, 24]. These two studies also found that 
hospitals with a catheterization lab treat 53% (in the US) and 25.4% (in Europe) 
of patients with a diagnosis of NSTEMI with PCI. Researchers from the clinical 
trial, TIMI IIiB [25], found three significant independent predictors of late positive 
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troponin, a confirmatory biomarker for MI, (1) levels for patients presenting with 
ACS and early negative troponin levels: TIMI 3 (OR=3.52, 95% CI = 2.38-5.23, 
p<0.001), (2) ST-deviations (OR=2.91, 95% CI =1.92-4.40, p<.001), and (3) no 
prior use of beta blockers (OR=1. 74, 95% CI=1.15-2.63, p=.008). 
For patients with a high-risk score, most studies have found that an early 
aggressive reperfusion therapy, PCI or CABG, resulted in better clinical 
outcomes when compared to a conservative therapy of pharmacologic agents 
(Table 1). In FRISC II, a clinical trial comparing early invasive with non-early 
invasive strategies at one year follow-up found that the composite outcome of 
death or MI occurred in 10.4% of those in the early invasive arm and 14.1 % of 
those in the non-early invasive arm with a p-value of 0.015 [26]. A new meta-
analysis by Dr. Keith Fox found that an aggressive approach leads to better long-
term outcomes when compared to a more selective conservative strategy (Table 
2) [27]. The decision between PCI and CABG is primarily based on anatomical 
and physiological characteristic of the injury. For example: left main coronary 
artery disease, compromised left ventricular function, diabetes, and/or three or 
more vessel injuries are treated with CABG, while two or fewer vessel injuries are 
reperfused with PCI [2]. 
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Table 1. 30-day and 6-month mortality rates stratified by aggressive and conservative therapy. 
30 - days 6 - Months 
Study Aggressive Conservative Aggressive Conservative 
Therapy Therapy Therapy Therapy 
1.96 
Neumann 
5.9% 11.6% (1.01,3.82) NA NA NA 
et al. [28) 
p=0.025 
.67 (.5, .91) .78 (.62, 
7.4% 10.5% 15.9% 19.4% .97) 
1 
p=0.009 I p=0.025 
Morrow 
.54 (.4, 
7.4% 16.2% 15.3% 25% .73) 
et al. [30) 
p<O.OOl 
Table 2. Cox regression of outcomes stratified by selective and routine invasive procedures.[28-30] 
Outcomes Selective Invasive Routine Invasive Hazard Ratio p-value 
MI 12.9% 10.0% 0.77 .001 
CV death 8.1% 6.8% 0.83 .068 
CV death/MI 17.9% 0.81 .002 
All-cause mortality 11.7% 10.6% 0.90 .190 
All-cause mortality IMI 20.9% 18.1% 0.85 .008 
Similarly, a myriad of clinical studies and retrospective studies based on 
registries have been conducted to investigate the difference in clinical outcomes 
between primary PCI and thrombolytic therapy. A vast majority of the studies 
have concluded that PCI resulted in better long-lasting outcomes when 
compared with fibrinolytic therapy (Table 3). In a small trial by Zijlstra, tests for 
differences in unconventional outcomes that relate to an individual's long-term 
functioning were performed showing those managed with PCI had less unstable 
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angina (5.7% vs. 19.4% p=0.02), more left ventricular ejection (51 vs. 45 
p=0.004) and more patency in the related artery (91 vs. 68 p=0.001) [14]. 
Likewise, the GUSTO lib analysis concluded that PCI was superior to 
thrombolytic therapy. In 30-day follow-ups, a composite outcome of death, non-
fatal re-infarction, and disabling stroke was measured in patients randomized to 
PCI and thrombolysis showing PCI's superiority in this composite outcome (9.1 % 
vs. 13.7%, p=0.013). The DANAMI-2 clinical trial also showed that PCI was 
superior to fibrinolytic therapy when it was stopped in the second interim study 
with a p-value less than 0.009 in favor of PCI [31]. 
Furthermore, the advent of stents and drug-eluting stents has resulted in 
superior outcomes in the latest trials and PCI-registry analyses [2]. In a meta-
analysis comparing randomized clinical trials of primary PCI versus 
Thrombolysis, researchers found that the odds ratio of mortality at six weeks was 
0.56 (0.33, 0.94), demonstrating that PCI was favorable [32]. 
A key aspect of these studies is the time to reperfusion subsequent to 
hospital admission. The optimal time to reperfuse via PCI technique has been 
determined to be 90 minutes or less [10]. For instance, a cohort study based on 
the American College of Cardiology's National Data Registry indicated that longer 
door-to-balloon times were associated with a higher risk of mortality in hospitals 
[33]. The risk of in-hospital mortality increased from 3.0% with a 30-minute door-
to-balloon time to 8.4% with a door-to-balloon time of 180 minutes in non-linear 
fashion and with a p-value less than 0.001. 
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Table 3. Long-term Outcomes: PCI vs. Fibrinolytic Therapy. 
In-hospital 6 - Months / 1 - Year 
Authors Outcomes p-
PCI Thrombolysis PCI Thrombolysis p-value 
value 
Grines et Death 2.6% 6.5% 0.06 NA NA NA 
aU20] 5.1% 12.0% 0.02 8.5% 16.8% 0.02 
Zijlstra et Death 0.0% 6.0% 0.13 NA NA NA 
aU14] Reinfarction 0.0% 12.5% 0.003 NA NA NA 
Ribichini Death 1.8% 5.5% 0.6 3.6% 7.3% 0.7 
et aU13] 9.1% 0.2 5.5% 45.5% 0.0001 
Le May et Death 4.8% 3.3% 1.0 4.8% 3.3% 1.0 
aU34] Reinfarction 11.3% 42.6% 49.2% 0.001 
Schoming Death NA NA NA 8.5% 23.2% 
et aU35] NA NA NA 10% 34.9% 
Issue with Primary PCI in the hospital without onsite CABG Capabilities 
An inherent risk to performing primary PCI is accessing or puncturing the 
femoral artery, which is a large artery, and may lead to a patient "bleeding out" 
very fast and leading to the patient's death if not corrected quickly. Also, issues 
may arise during the procedure such as an abrupt closure of the previously 
opened artery. Patients with elevated risks for MI and other co-morbidities may 
need to be transferred to an operating room that is capable and equipped to 
perform open-heart surgeries. Therefore, it is recommended that facilities 
performing PCI's should have appropriate onsite back-up surgical 
capabilities[10]. 
The decision to allow hospitals without CABG capabilities to perform 
primary PCI rests on each state's regulatory body. While the American College 
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of Cardiology/American Heart Association (ACC/AHA) guidelines give primary 
angioplasty without surgical backup a class 2b indication ("probably reasonable"), 
30 states currently allow hospitals without surgical open heart surgery (SOS) 
capabilities to perform primary (emergency) PCI. A myriad of studies, mostly 
retrospective, have shown that no difference in clinical outcomes exists between 
hospitals with CABG capabilities and hospitals without surgical backup for 
primary PCI[22, 36-43]. In the study "The Cost-effectiveness of the Kentucky 
Pilot Project of Allowing Primary PCI at Hospitals without Onsite CABG 
Capabilities" by Ramos in 2010, it is investigated how cost-effective it is to allow 
select facilities lacking emergency CABG capabilities to perform emergency PCI 
given that these facilities meet recommendations concerning screening criteria, 
surgeons' experience, and facility's volume [44]. By performing a meta-analysis, 
robust event rates estimates were derived, and the National Inpatient Sample 
2005 was used to obtain respective therapeutic alternatives cost estimates. 
Total charges from this dataset were used as a surrogate to costs since the latter 
are considered proprietary information to insurance companies; and neither 
transportation nor patient's personal caregiver expenditures were estimated due 
to the lack of a source thereof. This study was based on cost per death adverted 
instead of quality of live measures. However, quality of life data from patients 
such as preference on proximity of the facility providing PCI, reduction on door-
to-balloon time, and access to primary care provider could have increased the 
cost-effectiveness of allowing facilities without onsite CABG capabilities to 
perform emergent PCI. This study concluded that the alternative to allow 
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Regional Hospitals as well to perform primary PCI dominated the other 
alternative of Only Allowing Hospitals with Onsite CABG to perform PCI. This 
means that allowing regional hospitals to perform primary PCI both incur fewer 
costs while also averting more deaths. The incremental cost-effectiveness ratio 
of allowing regional hospitals to perform PCI was -$41 K per death averted, when 
compared to the option of Only Hospitals with On site CABG (Table 4). Hence, 
allowing regional hospitals to perform PCI will save $41 K per death averted. This 
evidence establishes this alternative as a cost-effective way in which to provide 
primary PCI in the State of Kentucky and supports the allowing of regional 
hospitals (that meet the recommendations outlined in Myers et al) to perform 
primary PCI. 
Table 4. Cost Effectiveness Analysis 
Strategy 
Only Hospitals with onsite CABG 







-$286.19 K -$41,164.25 
Many of the retrospective studies have found that many cases of MI 
originate in rural areas where most hospitals lack open-heart surgery capabilities 
[22, 40, 42] . Between 1998 and 2002, Alamance Regional Medical Center 
offered primary PCI under the guidance of Duke University Medical Center as 
part of a pilot program [40] . The inclusion criteria were those of low to moderate-
risk patients according to the literature. A total of 561 interventions were 
performed with a success rate of 98%, adverse events included one death due to 
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acute renal failure after successful PCI, while the other 2% of the patients were 
transferred to Duke Medical Center where 0.7% had to undergo bypass surgery 
(successfully). Magic Valley Regional Medical Center (MVRMC) in Twin Falls, 
10, implemented a program of providing PCI for acute coronary syndromes in a 
rural setting without surgical backup starting in 2003 [37]. It compared its 
outcomes with those of the ACC registry of 2004, which are considered the 
standard of care. The distributions of door-to-balloon times were statistically 
significant with that of MVRMC lower than that of the ACC registry. The in-
hospital death rates were 1.96% for MVRMC and 1.16% for the ACC registry 
(p=0.1446) indicating a not significant difference. Only one patient had to be 
transferred for open-heart surgery after the perforation of the left anterior artery. 
The transport time to Boise was 100 minutes, and the surgery did not have any 
complications. 
In 2000, the New York State Department of Health, which has a Certificate 
of Need system for limiting the number of hospitals in which CABG surgery and 
PCI can be performed, began to allow a limited number of hospitals to perform 
emergency (primary) PCI for patients with STEMI. By 2006, a total of 11 
hospitals were certified to perform PCI without surgical backup (henceforth called 
P-PCI centers). This study compares patient outcomes for patients with STEMI in 
those hospitals with patient outcomes in full service (FS) cardiac hospitals 
(hospitals that perform CABG surgery as well as P-PCI and elective PCI) (Table 
5) [38]. The PAMI-No SOS study showed that primary PCI in high-risk STEMI 
patients in hospitals without on-site cardiac surgery is safe, effective and faster 
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than primary PCI after transfer to a surgical facility[43]. Locally, the state of 
Kentucky conducted a pilot study to investigate the soundness of allowing select 
facilities in the state to perform primary PCI despite being devoid of onsite 
emergency backup capabilities [36]. It concluded that clinical outcomes were not 
different between the local hospitals and the national standard and that study 
populations were similar to those of national PCI registries. 
Table 5. Short-term Outcomes: PCI-Centers vs. FUll-Service Centers. [38] 
In-hospital/30-day mortality 















As early as 1994, the Mayo Clinic conducted a study to compare costs of 
immediate PCI and thrombolytic therapy for acute coronary syndromes [45]. The 
Mayo Clinic's hypothesis was that thrombolysis followed by adjunctive medical 
treatment was more cost-effective than angioplasty. However, the researchers 
arrived at the conclusion that there was no difference in cost-effectiveness within 
a twelve-month period. 
In 1993, the Health Technology Assessment Programme in the UK 
embarked in a long-term cost-effectiveness analysis of primary angioplasty 
taking the perspective of the UK's National Health System (NHS) with the 
subsequent results published in 2005 [46]. Their results consistently and 
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convincingly demonstrated a clinical advantage of immediate PCI over 
thrombolysis. No evidence was found suggesting that services should be 
concentrated to large hospitals in metropolitan areas despite evidence that larger 
volumes of the procedure resulted in lower levels of mortality. The economic 
evaluators compared PCI with thrombolytic therapy for people with AMI; they 
found that PCI was more cost-effective than thrombolysis even when taking into 
account variations in the cost of drugs and health status of the patients. In 2009, 
Khot et al. conducted a small prospective analysis of the costs related to 
reducing the door-to-balloon time for STEMI patients at St. Francis Hospital and 
Health Center (Beech Grove and Indianapolis, IN)[47]. They concluded that the 
payers obtain all of the financial benefits of reducing DTB in STEMI patients, both 
during initial hospitalization and after one-year follow-up. 
Coronary Artery Bypass Graft Surgery 
During angiography, the number of obstructed vessels is determined. If 
the left main coronary artery is seriously narrowed or obstructed, then coronary 
artery bypass graft surgery is recommended. CABG is also the treatment of 
choice when severe coronary artery disease is revealed during angiography. 
However, coronary artery bypass surgery remains controversial as a treatment 
for ongoing acute myocardial infarction. CABG is now considered when ongoing 
ischemia persists in patients who have been previously treated with angioplasty 
or fibrinolytic therapy. CABG is a procedure that creates new routes around the 
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blocked or severely narrowed arteries by transplanting a healthy blood vessel 
from another part of the patient's body. 
The development of coronary artery bypass graft surgery may be traced to 
the Vineberg procedure, which was first implemented in April 1950. The 
Vineberg procedure consisted of implanting an internal mammary artery into a 
left ventricular myocardium. However, this procedure was not received with 
enthusiasm within the medical community, as its physiologic benefits could not 
be fully documented; coronary angiography had not been developed yet. The 
first true graft surgery recorded seems to have taken place in 1958, and it 
seemed that it was in response to a procedural accident. William Longmire was 
performing a coronary endarterectomy when a right coronary artery 
disintegrated. He then decided to graft an internal mammary artery to restore 
blood flow. It was not until 1964 that the first aortocoronary saphenous vein graft 
was successfully recognized; Doctors Debakey and Garret had then an 
experience similar to that of doctor Longmire. They performed a left anterior 
descending coronary endarterectomy, which had to be salvaged by an 
aortocoronary saphenous vein graft. Their patient survived the surgery and had 
an unobstructed aortocoronary saphenous vein graft when restudied eight years 
later. With the development of angiography by Sones and Shirey in 1958, the 
need for proof of increased perfusion began to be met. By 1964, Mason Sones 
had accumulated an extensive number of cineangiograms that demonstrated the 
safety and efficacy of a saphenous vein graft for single-vessel coronary artery 
disease. A dramatic increase in the application of these techniques ensued, and 
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coronary artery bypass operations became the most frequent surgical procedure 
in the United States within a decade. 
The cardiac surgeon will make an incision, usually about 10-inches long, 
in the middle of the patient's chest. Then, the surgeon proceeds to separate the 
breastbone to have access to the heart and aorta. At this point, the patient is to 
be connected to a heart-lung bypass machine. The surgeon stops the patient's 
heart and cross clamps the aorta. To minimize damage, the heart is cooled with 
a solution of iced water and salt, and a preservative solution is injected into the 
coronary arteries. Plastic tubes are connected to the right atrium to channel 
venous blood out of the body to the heart-lung machine, which adds oxygen to 
the blood and circulates it through the patient's body. 
The doctor proceeds to remove a vein or artery from another part of the 
body, usually the saphenous vein from the leg, the radial artery from the forearm, 
or a portion of the internal mammary artery from the chest. The surgeon creates 
a new blood route by sewing one end of the recently grafted vessel to the 
coronary artery beyond the lesions and the other end to the aorta. At this point, 
the surgical team will restore blood flow to the heart, which usually starts beating 
again on its own or is electrically shocked. The patient is disconnected from the 
heart-lung machine, and tubes are inserted into the patient's chest to drain fluid. 
The surgeon proceeds to reconnect the breastbone with wire, which remains 
within, and sew the incision closed. Coronary artery bypass graft surgery usually 
takes between four and six hours; afterwards, the patient is transferred to an 
intensive care unit for at least two days. 
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Goals and Objectives 
The goal of this study is to use a data mining framework to assess the 
three main treatments for acute myocardial infarction and their variants: 
thrombolytic therapy, percutaneous coronary intervention (percutaneous 
angioplasty), and coronary artery bypass surgery. The need for a data mining 
framework in this study arises because of the use of real world data rather than 
highly clean and homogenous data found in most clinical trials and 
epidemiological studies. The assessment is based on determining a profile of 
patients undergoing an episode of acute myocardial infarction, determine 
resource utilization by each treatment, and creating a model that predicts each 
treatment resource utilization and cost for a distinct subject. 
Text Mining and unsupervised clustering is used to find a subset of input 
attributes that characterize subjects who undergo the different AMI treatments as 
well as distinct resource utilization profiles. Classical statistical methods are 
used to evaluate the results of the clustering techniques. The features selected 
by unsupervised learning will be used to build predictive models for resource 
utilization and compared with those features selected by traditional statistical 
methods for a predictive model with the same outcome. Sequence, Association, 
and Link analysis is used to determine the sequence of treatment of acute 
myocardial infarction. The resulting sequence is used to construct a probability 
tree that defines the basis for cost effectiveness analysis that compares AMI 
treatments and their variants. To determine effectiveness, survival analysis 
methodology is used to assess the occurrence of death during the 
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hospitalization, the likelihood of a repeated episode of acute myocardial 
infarction, and the length of time between reoccurrence of an episode of acute 




Data mining represents the combined efforts of several well-established 
fields: classical statistical analysis, machine learning, artificial intelligence, and 
the development of large databases. Because the convergence of these 
domains makes up the whole of data mining methodology, it means that 
inductive and deductive methods have active roles in knowledge discovery, 
which is better defined by Fayyad [48] as "the non-trivial process of identifying 
valid, novel, potential useful, and ultimately understandable patterns of data." In 
turn, data mining seeks to leverage these patterns into models that lead to 
actions and decisions to increase benefit in some form. However, data mining 
goes further because it involves an iterative closed-loop system for the 
evaluation of models and their ability to be adapted to other data sets. 
The first step in data mining focuses on the discernment of faint patterns 
by analysis algorithms that can evaluate nonlinear relationships between 
predictor variables themselves and their targets. Typically, machine learning 
enables these tasks of exploratory data analysis and they include rule discovery, 
clustering, descriptive generalizations, feature selection, and classification. 
Exploratory data analysis is one of the major activities within a data mining 
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project. It includes interactive and visual techniques that allow one to view a 
data set in terms of summary statistical parameters and graphical display to get a 
feel for any patterns or trends that are in the data set. After interactively 
exploring a data set, descriptive modeling follows. This undertaking involves 
forming data set views at a higher level. For instance, one may wish to 
determine overall probability distributions of the data, also known as density 
estimations. One may also want to create dependency models describing the 
relationship between variables. 
Another activity encompassing descriptive modeling is that of data 
partitioning. It consists in either cluster analysis or data segmentation. Cluster 
analysis tries to find natural groups with many clusters or a user's specified 
number of clusters. For segmentation, the goal is to find homogeneous groups 
related to the variable to be modeled. For instance, in business a highly sought 
segment is that of customers who are big-spenders. 
A third activity of data mining is predictive modeling. This activity consists 
of building a model where the value of one variable can be predicted from the 
value of other variables. When the variable whose value is to be predicted 
consists of categories, such as Yes/No, multiple choice, 'from 0 to 5', the model 
is referred to as classification. On the other hand, when the predicted variable 
consists of a continuous range of values such as values between 0 and 1, age of 
a person, blood pressure, number of visits to a primary doctor, the model is 
referred to as regression. Data mining also involves discovering patterns and 
rules as well as the activity known as retrieval by content. The former attempts 
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to find combinations of items that occur frequently together in transaction 
databases such as finding genetic patterns in DNA microarray assays. The 
latter, retrieval by content, begins with a known patterns of interest and follows 
the goal to find similar patterns in the new data set. It is mainly used in pattern 
recognition within text material or image data. 
The method followed in data mining process for analytics is a blend of 
mathematical and scientific methods [49]. Both the mathematical and scientific 
methods include five basic steps. Mathematical methodology involves the five 
basic steps of understanding, analysis, synthesis, review, and extension, while 
the scientific method includes the five basic steps of characterization from 
experience and observation, hypothesis generation, deduction, test, and 
experimentation. The basic data mining process flow follows the mathematical 
method, but some steps from the scientific method are included, for instance, 
characterization, test, and experimentation. This process has been 
characterized in numerous but similar formats. The format followed in this 
dissertation is known as SEMMA: Sampling, Explore, Modify, Model, and Asses 
[49]. The step of sampling involves the creation of one or more data tables. 
These samples should be large so that they contain significant information; yet 
they should be small enough so that they can be processed in timely fashion. In 
the exploration step, one searches for anticipated relationships, unanticipated 
trends, and anomalies in order to gain understanding and ideas. Modifying the 
data includes not only selecting existing variables but also transforming existing 
variables and creating new ones upon which the model selection process 
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focuses. Data modeling uses analytical tools to search for combinations of the 
data that dependably predicts a desired outcome. Finally, while assessing the 
data, one evaluates the usefulness and reliability of the finding from the data 
mining process. 
Rule Discovery: Association and Sequence Rules 
Rule discovery, also known as association rules, has as a goal the 
detection of relationships or associations between specific values of categorical 
data variables in large databases. Association rules fall in the realm of 
unsupervised learning that seeks to describe the joint distribution of N variables. 
In other words, if one has a set of N observations (X1, X2, ... ,XN) of a random 
vector X with joint density Pr(X), one seeks to infer the properties of this 
probability density without the help of a supervisor or teacher providing correct 
answers or a degree-of-error for each observation [50]. Because of the high 
dimensionality of large databases, most non parametric methods fail to estimate 
this density distribution appropriately. In the case of association rules, the 
problem is somewhat simplified by changing the goal to finding the joint values of 
the variables Z = {Z1, Z2, ... , ZN} appear most frequently within the database. 
Variables are abstracted to binary values Zj E {O, 1}, where Zij = 1 if the jth 
variable is present or Zij = 0 otherwise in observation i. This method is more 
clearly described in the context of sales transaction analysis where its origins lie. 
Each variable is assigned one of two values; Zij = 1 if the r item is purchased as 
part of a transaction, whereas Zij = 0 if it was not purchased. Those variables 
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that frequently have joint values of one represent items that are frequently 
purchased together. This information can be very useful in the segmentation of 
customers based on buying patterns. In the case of health outcome analytics, 
this information can be used in the segmentation of a population based on 
diseases and treatments. 
In more general terms, the goal of association rule analysis is to find a 
collection of prototype X-values V1, V2, ... ,VL for the feature vector X, such that the 
probability density of Pr(vl) evaluated at each of those values is relatively large. 
The algorithm seeks regions of the X-space with high probability content relative 
to their size or support. Let Sj represent the set of all possible values of the r 
variable, its support, and let Sj be a subset of the values in Sj. The goal can be 
stated as finding the subsets of variable values S1, S2, ... ,sp such that the 
probability of each of the variables simultaneously assuming a value within its 
respective subset pr[n(Xj E sJ] is relatively large. 
}-I 
p 
The intersection of subsets n( Xj E Sj) is called a conjunctive rule. 
j-l 
However, general approaches are not feasible for very large databases where 
p=104 and N=108. A further simplification is to consider the integers J={1, 2, ... , 
p} and corresponding values VOj, j in J such that pr[n (Xj = VOj )] is large. Binary-
jEJ 
valued dummy variables are used in seeking a solution. The support for Sj is 
finite for each variable Xj. A new set of variables Z1, ... ,Zk is created, one such 
variable for each of the values Vlj attainable by each of the original variables X1, 
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X2, ... , Xp. The number of dummy variables K is K = ~ISjl, where IS jl represents 
j-I 
the number of distinct values attainable by Xj. Each dummy variable Zk is 
assigned a value of one if the variable with which it is associated takes on the 
corresponding value to which Zk is assigned, and Zk is assigned to zero 
otherwise. This means that pr[n (Xj = VOj )] is transformed into finding the 
jEJ 
integers KC {1,2, ... ,K} such that pr[n (Zk = 1)] = pr[n Zk = 1] is large. Here, the 
kEK kEK 
set K is called an item set. The number of variables Zk in the item set is called 
its size. This means that the estimated value of the last expression is a fraction 
of observations in the database for which the conjunction is true: 
i4[n (Zk = 1)] = ~ i n Zik' where Zik is the value of Zk for this ith case. This is 
kEK N i-I kEK 
also called the support or prevalence T(K) of the item set K. Note that an 
observation i for which n Zik = 1 is said to contain the item set K. Thus, the 
kEK 
algorithm returns high support item set K's in the form of association rules. The 
items Zk, k in K, are partitioned into two disjoint subsets, A U B = K, and written A 
~ B where A is called the antecedent and B the consequent. 
Each association rule has several properties based on the prevalence of 
the antecedent and consequent item sets in the database [49]. These properties 
are numbers whose magnitude describes the strength of the association rule. 
The support of the rule A ~ B is the fraction of observations in the union of the 
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antecedent and consequent, which is simply the support of the transaction or the 
item set K from which it is derived. This is an estimate of the probability of 
simultaneously observing both item sets A n B in a randomly selected rule, 
Pr(A nB), which is the number of transactions containing both A and B divided 
by the number of antecedents. The confidence of A -7 B is its support divided by 
Pr(AnB) . 
the support of the antecedent: Pr(A) = Pr(B I A). The third number or 
measure of strength of an association rule is the lift, which is equal to the ratio of 
. Pr(BIA) 
the confidence to the expected confidence or support of B: Pr(B) 
Furthermore, sequence analysis is concerned with the order in which a 
group of items was purchased and focuses on discovering temporal structural 
relationships. Note that the general sequence analysis, which deals with a 
multitude of transactions, can be adapted to frequent episode discovery. The 
latter addresses the problem of finding frequent episodes in a temporal data 
sequence. Here, an episode is considered a sequence of events appearing in a 
specific order within a specific time window; for instance, the occurrence of 
myocardial infarction followed by cardiac arrest. 
In health analytics, this can be abstracted to the order of disease 
diagnoses or the order of procedures to treat an ailment. Useful sequence rules 
are not always obvious, and sequence analysis helps one extract these rules 
regardless of how hidden they may be in the database. The visualization of 
these rules, link analysis, aids one to construct a map of the connections 
between items, and the strength of such connections is represented by the 
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thickness of each line connecting any two items linked together in an association 
or sequence rule. 
Clustering 
The purpose of clustering methods is to detect similar subgroups among a 
large collection of cases and to assign those observations to the clusters in such 
a manner that cases within a group should be more similar to each other than to 
cases in other clusters [49]. In addition, cluster analysis helps one form 
descriptive statistics to ascertain whether or not data consist of a set of distinct 
subgroups with each cluster representing items with substantially different 
properties. At the core of clustering is the idea of grouping objects based on a 
definition of similarity within the algorithm. This definition is based, in turn, on the 
choice of distance or affinity measure between two objects [50]. 
Frequently, one has measurements Xij for i = 1, 2, ... , N, on variables j = 1, 
2, ... , p. First, pairwise dissimilarities between observations are denoted by dj(Xij, 
Xi'j) between the values of the r variable. Then one defines 
p 
D(Xi,Xi,) = 2dj(Xij,Xtj ~ as the dissimilarity between objects i and i'. Some 
j-l 
common choices to measure lack of affinity are: 
2 x· Xi = j IJ 
P 
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4. Categorical Variables: assume the variable has M distinct values; then, 
5. Ordinal Variables: usually represented by contiguous integers as an 
ordered set. If there are N original values, then their realizations are 
j-~ 
replaced by N 2, j E {I, ... , N} and treated as quantitative variables on 
this scale. 
One sees that the clustering algorithm partitions the observations into 
groups so that the pairwise dissimilarities between those assigned to the same 
cluster tend to be smaller than those assigned to different clusters. However, the 
algorithms fall in three distinct types. Combinatorial algorithms work directly on 
the data with no direct reference to an underlying probability model. Mixture 
modeling supposes the data define an independent and identically distributed 
sample from some population described by a probability density function, which 
is parameterized and fitted by maximum likelihood or Bayesian approaches. The 
third type is the mode seeker algorithm, which is not parameterized. This 
method attempts to estimate distinct modes of the probability density function; 
observations nearest to each respective mode are then clustered together. 
Text Mining and Clustering 
Text mining is the process of discovering new, previously unknown, 
potentially useful information from a variety of unstructured data sources, 
including business documents, customer comments, web pages, and XML files. 
35 
Language, although complex, can be studied by considering its simpler 
properties based on counting and text pattern matching. The latter identifies 
letters or characters in a document or string; however, it may focus on rejecting 
words that contain a string of letters of interest that are not related. The process 
of counting the number of matches to a text pattern occurs repeatedly in text 
mining, such that one can compare two different documents by counting how 
many times different words occur in each document. In addition, the language 
can be checked against large language collections, called corpora. After the 
computer algorithm has found the example of usage, analysts can attribute 
meaning to these discovered patterns. This blend of human and computer 
discovery is a back and forth process that is repeated as many times as 
necessary similar to the design of experiment process in industrial process 
control and quality control. Following a given design, one may proceed through 
several iterations, harvesting preliminary insight from previous iterations of the 
experiment, then adjusting input parameters and running the experiment again 
until the results show an F-value significant at the 95% level of confidence. 
Mining documents' text helps one understand them without reading every 
single word thereof. This allows the discovery of the underlying themes and 
concepts within collections of large documents [49]. Within text mining, there are 
two basic applications: predictive text mining and descriptive text mining. The 
latter focuses on uncovering the themes and concepts within a collection of texts. 
One of the main outcomes of descriptive text mining is that of clustering 
documents into meaningful groups and reporting the concepts that discovered 
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within the clusters. On the other hand, predictive text mining encompasses the 
classification of documents into categories and using the implicit information in 
the text for decision-making. Predictive text mining involves examining historical 
data to predict future outcomes. 
In health sciences, a large part of the documentation of patient care exists 
in the form of charts and notes, which must be extracted manually for billing and 
insurance purposes. In this case scenario, text mining may offer a lower cost 
process to transfer that information. Another interesting use of text mining is to 
gather data from the Internet in the form of medical journal articles meeting 
predetermined criteria with the purpose of conducting a meta-analysis on the 
subject of interest. 
Text Clustering defines a small number of groups of documents so that 
document within the same cluster are related and documents in different groups 
are not closely related [49]. This is usually achieved by looking at terms within 
each document. Documents within a cluster are represented by a list of terms, 
and those terms appear in most of the document within the group with a large 
frequency. 
In medical databases, patients' conditions and treatments are often 
recorded with standard numeric codes, called ICD-9 codes. These codes consist 
of five digits and can be considered nominal data represented in text format. 
ICD-9 codes have stemming properties resembling words and text. Some of its 
digits identify a general category, while other digits identify a more specialized 
category. For instance, the first three digits of 41 0 represent acute myocardial 
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infarction (AMI); 4101 represents an acute myocardial infarction of the anterior 
wall while 41001 represents an acute myocardial infarction of the anterior lateral 
wall. The fifth digit takes, in this case, takes on the values 1 and two representing 
the first episode of care and subsequent episodes of care respectively. This 
means that by combining the codes for a hospital stay, a text document for this 
stay is built and records all the illnesses or diagnoses the patient experienced 
during the inpatient visit. These documents can be analyzed with text mining to 
find similarities between codes in patient conditions, taking full advantage of the 
stemming properties contained within ICO-9 codes. 
Kernel Density Estimation 
Often, analysts assume that the underlying distribution of covariates is 
bell-shaped, which is often not true when the population is not homogeneous. In 
these cases, non parametric estimation is usually more reliable [49). Kernel 
density estimation is an unsupervised, nonparametric learning procedure that 
estimates the probability density function of a variable or feature. Let X1, .. , ,Xn 
denote the observed data, a sample from unknown f. The kernel density 
estimator is defined to be J(xt =.!. ~ .!.K(X-Xi) where h is a positive number, 
n i-I h h 
called the bandwidth; and K is a kernel or smoother function with the following 
properties: 
1. K{x)~O 
2. fK{x)dx =1 
3. f X' K{x)dx =0 
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The kernel density estimator puts a smoothed-out lump of mass of size 1 In 
over each data point Xi. The bandwidth h controls the amount of smoothing. 
A 
When h is close to zero, In consists of a set of spikes, one at each data point. 
The height of the spikes tends to infinity as h tends to zero. When h tends to 
A 
infinity, In tends to a uniform density. The kernel K can be any density function; 
however, the Gaussian kernel is usually preferred despite many studies 
indicating the limited impact of the value of K. 
Generalized Linear Models 
The goal of generalized linear models is to describe explanatory variables 
effects on a response variable. These are regression models encompassing 
non-normal response distributions and modeling functions of the mean [51]. 
Within this framework, effects are evaluated, relevant interactions are included, 
and smoothed estimates of responses are provided. Generalized Linear Models 
consist of three components: random component, systematic component, and a 
link function. Hence, a generalized linear model is a linear model for a 
transformed mean of a response variable that has a distribution in the natural 
exponential family. 
The random component consists of the response variable denoted by Y 
and its probability distribution [52]. The latter must belong to the natural 
exponential family of probability density functions with the following form: 
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The components of this family of probability distributions can be described as 
• OJ is the natural parameter, which characterizes central tendency. 
• cp is a parameter of dispersion. 
• i = {1, 2, 3, ... , N}. 
When cp is known, then (1) simplifies to 
In this case, one can identify the components of equation (2) with the 
components of equation (1) as follows: 
• d(e.) = exp {_ b(e i)} 
I a(~) 
e· 
• Q(e) - ! i - a(~) 
• ei may vary for i = {1, 2, 3, ... , N} depending on the value of explanatory 
variables. 
• Q(ei ) is a function of the natural parameter. 
• Some examples of distributions belonging to the natural exponential 
family are then normal distributions, the binomial distribution, and the 
Poisson distribution. 
The systematic component relates a vector (nv n2, n3' ... , nN) to the 
explanatory variables through a linear model [51]. Let Xij be the value of the 
predictor for j = {1, 2, ... , p} and for the subject i = {1, 2, 3, ... , N}; this means that 
the systematic component is expressed as the linear combination of explanatory 
variables: 
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ni = LPjXij,i = 1,2,.",N 
j 
In other words, the systematic component is defined as a linear predictor. 
The link function is simply a function g of the mean 11 = E(Yi), which connects 
the expected value to the systematic component Ili to ni in the following fashion: 
The function g must be monotonic and differentiable on its support. This 
means that the link function expresses a transformation of the expected value of 
the outcome as a linear combination of predictors. When the link function 
transforms the mean to the natural parameter, the link function is called the 
canonical link: 
B(lla = Q(ea = L PjXij; i = 1,2, "., N is the canonical case (4) 
j 
In the case of a continuous response, GLM's model the response under the 
assumption of a continuous distribution with constant variance across input 
levels, which is in the family of natural exponential distributions, including 
dispersion parameters. Then the normal distribution of the outcome has the 
following probability density function: 
1 {-(Y -1l)2} fey; 11, a) = a -{ZIT exp 20'2 (5) 
To see that the normal probability density function belongs to the natural 
exponential family, one can identify the components of (1) with those in (5) as 
follows: 
• e = 11 
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• qJ = a 
• a(a) = a 2 
2 
• b(J.l) = L 
2 
• c(y; a) = _L + log (_1_) 
2/12 /15 
The mean is its natural parameter. In turn, this means that an ordinary 
regression model for H(Y) is a GLM using the identity link: 
gCJ.la = J.li = I f3j Xij ; i = 1,2, ... , N is the linear case (6) 
j 
Even in the case of a categorical explanatory variable with a normally 
distributed random component, the regression model is a GLM more commonly 
known as Analysis of Variance (ANOVA). Furthermore, if the explanatory 
variable is mixed, continuous and categorical, the statistical model falls under the 
family of GLM's and is known as Analysis of Covariance (ANCOVA). 
Binary data representing success and failure outcomes by 1 and 0 can be 
modeled by generalized linear models as well. The distribution, which is 
Bernoulli, describes probabilities of success and failure as P(Y = 1) = rr and 
P(Y = 0) = 1 - rr respectively and the expected value of Y as H(Y) = rr [52]. The 
variance for a binary response is given by var(Y) = rr· (1 - rr). It is well known 
that the probability mass function is described by: 
fey; rr) = rrY (1 - rr)l-y = (1 - rr)[rr/(1 - rr))Y 
= (1 - rr)exp(y log(rr/(1 - rr))) (7) 
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where y = 0 or y = 1. This function belongs to the natural exponential family (1). 
The components of this mass function can be identified with the components of 
equation (2) as follows: 
• 8i = rr for i = {1, 2, 3, ... , N} 
• 
d(8i ) = d(n) 
= I-n 
• Q(rr) = log (~) 1-7r 
In this case, the natural parameter Q(rr) = log [(1:7r)] is called the log odds of 
response 1 or the logit of rr [51]. The logit function is the canonical link and is 
used for constructing the GLM model as follows: 
This model is the called the logistic regression model. It reflects a 
nonlinear relationship between rr and the predictors xij' which is monotonic. This 
means that rr increases continuously or rr decreases continuously as the 
predictors Xij increase. While rr must be a number between 0 and 1, the logit 
can be any real number. This makes the logit model free of structural problems 
that are present in a linear probability model. 
There are cases when the outcome of interest represents possible counts 
such as the number of visits to a primary physician. The Poisson distribution is 
the simplest probability distribution, belonging to the natural exponential family, 
which can represent possible counts of an event. A key property of the 
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outcomes is that they can take any nonnegative integer value. To build this 
model, one lets Y represent a count, and its mean is denoted by J1. = E(Y) and 
variance var(Y) = J1. [51]. The Poisson probability mass function for the 
response variable Y is 
f{Y; 11) = e-P, .,IlY 
y. 
= exp( -1'). C,) exp(y log (I' )) (9) 
where Y = 0,1,2, .... 
It is easy to see that (9) has the form of the natural exponential family of 
probability distributions by equating its components as 
• dC/l) = exp( -J1.) 
1 
• hey) = -y! 
• Q(J1.) = log(J1.) 
Clearly, the natural parameter is logC/l). This means that the canonical 
link function g is the log link. When the GLM uses this link, the model is called a 
Poisson log linear model because the logarithm of the mean is represented as a 
linear combination of inputs. 
logC/la = I PjXij ,where i E {1, 2, ... , N} (10) 
j 
The log mean can take any real value like the linear predictor Lj Pj xij. 
For this model, the mean satisfies the exponential relationship 
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I' = exp (~/1JXij) = eP,x". eP'x" ..... eP'x" 
From this relationship, one can see that a one-unit increase in a predictor 
has a multiplicative effect of e f3 j: the mean at Xij + 1 equals the mean at xij 
multiplied by e f3 j. 
Generalized Linear Model parameter estimates are based on the 
paradigm of maximum likelihood estimation, which chooses values of the model 
parameters in a way that the distribution produced gives the observed data the 
greatest probability [53]. Given that GLM's are restricted to the exponential 
family of distributions for the random component Y, a single algorithm based on 
the least squares can be implemented to the entire family of models regardless 
of link function. The attractiveness of maximum-likelihood estimators is based on 
their asymptotic properties [51]. Consistency of the estimators means that the 
estimators converge in probability to the value being estimated. Normality at 
infinity means that as the sample size increases, the distribution of the ML 
estimator tends to the normal distribution centered at the true value of the 
parameter and variance of the reciprocal of the Fisher information function. 
Similarly, these parameters are asymptotically efficient because they achieve the 
Cramer-Rao lower bound as the sample size increases to infinity. 
The ML estimators for the exponential family or the random component 
are found by using the log-likelihood function L = Li Li where 
Li = log(t(Yi; 8i, <p)) denotes one observation's contribution to the log-likelihood: 
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To find the estimates, the log-likelihood is maximized by finding the first 
and second derivatives of (11): 
_aL .. = _y .. _--:-b '-:-( 0...:,.") 
a 0 .. a(cp) 
a2 Li _ -b" ( 0 .. ) 
ao .. 2 - a( cp) 
(12) 
(13) 
where b'(8a and b"(8i ) represent the first two derivatives of the function b(·) 
evaluated at 8i , then one applies the general likelihood results to (12) and (13) 
E(:~)=O (14) 
-E( :~~ ) = E(:~ r (15) 
These hold under regularity conditions, which are satisfied by the 
exponential family of distributions. If one applies the above results to one 
observation, one obtains from the first formula 
Ili = E(Yi) = b'(8i) (16) 
and from the second equation 
b"(8i ) (Yi - b'(8a)2 (Yi) -----:'~ = E = var 
a(cp) a(cp) [a(cp)] 
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Clearly, one can notice that the function b(·) determines all the moments 
of l-i. Now, when N independent observations are considered, the log-likelihood 
is given by 
where p = (f3v f3z, .,,' f3p) is the vector of parameters to be estimated, which 
reflects the dependence of 8 on the model parameters p. These results give one 
the following likelihood equations: 
N 
I (Yi - J1.D Xij aJ1.i = 0 ( ) , j = 1,2, .,,' p. . var l-i ar] i 
t=l 
(18) 
Explicitly P is not present in the above equations; however, it is there implicitly 
through J1.i = 9-1(Lj f3jXij). Since a GLM's random component is restricted to 
the natural exponential family of distributions, the likelihood equations depend on 
the distribution of l-i only through J1.i and var(l-i). The latter depends on the mean 
through a particular functional form var(l-i) = vCJ1.D for some function v, such as 
v(J1.D = J1.i for the Poisson distribution vCJ1.i) = J1.i (1 - J1.D for the Bernoulli 
distribution, and vCJ1.D = (Jz for the normal distribution. 
The maximum likelihood estimates 11 of GLM parameters are found by 
solving the nonlinear equations (18). To solve them, a general-purpose iterative 
method called the Newton-Raphson Method is used two ways to determine the 
maximum of a likelihood function [51]. This method begins with an initial guess 
for the solution. A second guess is obtained by approximating the function to be 
maximized in a neighborhood of the initial guess by a second-degree polynomial 
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and finding the location of that polynomial's maximum value. Then, it 
approximates the function in a neighborhood of the second guess by another 
second-degree polynomial, and the third guess is the location of its maximum. 
Thus, the method generates a sequence of guesses converging to the location of 
the maximum when the function is suitable and the initial guess is good. 
Mathematically, the Newton-Raphson method determines the value of P in the 
following manner. Let p' = (aLCP)/apl' aLcp)/ap2 • ...• aLCP)/app)and H 
denote the matrix having entries hab = a2LCP)/apaapb called the hessian matrix. 
Let J1. (t) and H(t) be J1. and H evaluated at pt, which is the guess t for p. Step t in 
the iterative process approximates LCP) near pt by terms up to second order in 
its Taylor series expansion: 
LCP) ~ LCpt) + p(t)' CP - pt) + (~) CP - pt)' H(t)CP _ pt) 
Then, one solves aLCP)/ap ~ J1.(t) + H(t)CP - pt) = 0 for p, which yields 
the next guess. This can be expressed as p(t+l) = p(t) - (H(t)r 1 p(t), 
assuming that H(t) is nonsingular. Iterations proceed until changes in between 
successive cycles are sufficiently small. 
Model selection within the GLM framework is based on the deviance 
statistic and evaluation of residuals [52, 53]. Given a specific GLM model and 
observations y = (yv Y2. Y3' ...• YN), the log-likelihood function denoted by LCJL. y) 
is expressed in terms of the means p = CJ1.1' J1.2 • ...• J1.N). The maximum of the log-
likelihood for the model can be denoted by L(Jl; y). If one considers all the 
possible models, one realizes that LCy; y) is the maximum that the function can 
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achieve. This occurs for the most general model, having a separate parameter 
for each observation and the perfect fit jl = y, which is called the saturated 
model. This model is not useful since it does not provide data reduction [51]. 
However, it serves as baseline for comparison with other model fits. Clearly, a 
saturated model explains all variation by the systematic component of the model. 
For a particular unsaturated model, the corresponding ML estimates can be 
denoted by 8i and Pi' For a particular unsaturated model, one can denote its 
maximized log-likelihood by L(jl; y) and for the saturated model by L(y; y). The 
likelihood-ratio statistic, which tests the null hypothesis that the model holds 
against the alternative that a more general model holds is given by 
_ ( maximum likelihood for model ) _ _ ("") _ ) 2109 maximum likelihood for saturated model - 2[L Il.y L(y.y]. 
This is called the scaled deviance or simply the deviance. The greater the 
scaled deviance, the poorer the fit is [51]. For most GLM's, the scaled deviance 
has an approximate chi-squared distribution. This statistic describes the lack of 
fit. One can explicitly express this statistic in terms of the natural exponential 
family of distributions (11) by 
Iy·8. - b(8.) IY'{}' -b({}.) 
-2[U-n ) - L( )] = 2 !! ! - 2 !! ! = D(y' "") \,JA-.y y.y . a(cp) . a(cp) • Il . (19) 
! ! 
If an overall goodness-of-fit test provides evidence that a GLM model fits 
poorly, one can examine residuals, which highlight where the fit is poor. The 
main type of residual evaluated is that proposed by Pearson, namely the 
Pearson residual: 
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When the model holds, Pearson residuals are less variable than standard 
normal because these residual compare Yi to the fitted means rather than the 
true mean. For instance, the denominator estimated (var(ya) liz = (var(Yi-
f.1.a) liz rather than (var(Yi - pa) liz. On the other hand, standardized residual 
divide the ordinary residual by their asymptotic standard errors. 
An important activity of data mining is predictive modeling, more 
specifically classification. It helps organizations identify different types of 
customers, physicians predict which patients are at high risk of cardiovascular 
disease, and businesses determine whether sales personnel are committing 
fraud [49]. Classification mainly aims to include or exclude observations in a 
small set of specific categories. Many methods for data classification exist; some 
of the most commonly used are neural networks, decision trees, and regression 
[50]. Given the myriad of classification methods, a very important aspect of this 
activity is to compare results to determine the best means of classification for a 
problem. One way to do this is by comparing the rates of correct classification 
and choosing the technique with the highest rate. However, when data are used 
to define the model, accuracy tends to be inflated. For instance, one can define 
a predictive model that is 100% accurate on a training set but 0% accurate on a 
validation set. This means that validation is paramount. Another difference 
between classical statistical inference and predictive modeling within a data-
mining framework is the use of a holdout sample. Its purpose is to reserve a 
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portion of the data to be used to test the accuracy of the model after the model 
has been defined. Thus, data mining focuses less on model assumptions and 
more on the model's ability to actually predict outcomes. In other words, 
assumptions are not as important as outcomes. 
Within health plans databases, the process of predictive modeling has 
gained a great deal of interest. Many constituencies operate under the principle 
of high risk and risk assessment; these include actuary, underwriting, medical 
management, marketing, and sales. In order to enhance these services, data 
mining leverages inductive and deductive methods for description and 
forecasting purposes, which align with organic systems such as the health care 
industry very well. With classical statistical models, this process involves rules 
based grouping and indirect correlations to complete the risk assessment and 
predictions. In each of these processes, the approach is usually linear and the 
units measured generally are in non-weighted amounts resulting in minimal 
predictive value. In turn, data mining algorithms provide prominent advantages 
to these classical modeling techniques: multiple weights for complex variables, 
multiple endpoints consideration with complex weighting, and identification of 
continuous variable discrimination points. In addition, data mining measures 
model accuracy in results rather than validating model assumptions. These 
differences create improved results measured by relative characteristic curves 
(ROC) AND R2 values. In addition, data mining techniques such as neural 
networks, decision trees, fuzzy logic, rule induction, and prinCipal components, 
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allow the modeling of variables in nonlinear relationships, which are more 
prevalent in complex clinical-financial relationships in the real world. 
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CHAPTER 3 
MarketScan® Commercial Claims and Encounters Database Description 
It contains person-specific clinical utilization and expenditures throughout 
outpatient, inpatient, and prescription drug services from approximately 45 large 
employers, health plans, and public organizations [54]. The database links paid 
claims and encounter data to patient information across types of providers and 
service sites over time. It includes private sector health data from approximately 
100 payers annually. These data represent the healthcare experience of insured 
employees, early retirees, and COBRA continues. The types of plans covered 
include fee-for-service plans, fully capitated plans, and partially capitated plans. 
The structure of the annually collected data consists of four databases: 
Medical/Surgical database, Outpatient Pharmaceutical Claims database, and 
Populations/Enrollment database. The Medical/Surgical database consists of 
three tables: Inpatient Admissions Table, Inpatient Services Table, and 
Outpatient Services Table. 
The data contained in the medical/surgical tables are of the upmost 
interest in this study. The Inpatient Admission Table summarizes a hospital 
admission, which is a group of medical/surgical services that include a room and 
board claim. Each record is constructed after all of the encounters or claims 
associated with an admission are fully identified. Included within each record is a 
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summary of facility and professional payment information. Combined, the tables 
for the years 2000 and 2001 contain 494,106 records and seventy-seven 
variables, see appendix A for a detail descriptions of all the variables. Of main 
interest are the fifteen diagnosis variables and fifteen procedures variable, which 
are applied chronologically based on service dates. The Inpatient Service Tables 
contain 8,719,966 records and sixty-four variables, see appendix 8 for a detail 
descriptions of all the variables. This table details each individual facility and 
professional encounter and service that comprise the inpatient admission record. 
The inpatient admission table and inpatient service table are linked by the 
identifier CASEID within the same year. 
The records in the Outpatient Service Table correspond to encounters and 
claims for services provided in a doctor's office, hospital outpatient facility, 
emergency room or other outpatient facility. The Outpatient Service Tables have 
117,781,365 records and fifty-four variables which include five diagnosis, one 
procedure, physician specialty, and place of service. However, a small 
percentage of these observations truly represent an inpatient admission, which is 
reflected by checking the values in the variable 'place of service.' The reason for 
this issue is that some claims do not show an explicit 'room and board' charge 
and hence are excluded from the inpatient admission table. A detailed 
description of these variables can be found in appendix C. 
The Outpatient Pharmaceutical Claims tables contain 751,148,837 
records and fifty-two variables, which are described in detail in appendix D. The 
records in these tables are linked to the medical/surgical tables by the variable 
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ENROLlD, enrollee 10. Each record represents a card program or mail order 
prescription claim; however, prescription drug plans with capitation arrangements 
are not represented in this database. To determine whether or not individuals 
are enrolled in plans with drug information each year, the RX variable within the 
Surgical/Medical Tables can be used. This variable will have a value of one if the 
individual is enrolled in health care plan, which encompasses a prescription plan 
while a value of zero will indicate otherwise. 











Acute myocardial infarction. The folloWing fifth-digit subclassification is for use 
with category 410: 0 episode of care unspecified, 1 initial episode of care, 2 
subsequent episode of care. 
Acute myocardial infarction. ST elevation myocardial infarction (STEM I) of 
anterolateral wall. 
Acute myocardial infarction. Infarction: anterior wall (with contiguous portion of 
intraventricular septum), anteroapical (with contiguous portion of 
intraventricular septum) ,anteroseptal (with contiguous portion of 
intraventricular septum), ST elevation myocardial infarction (STEM I) of other 
anterior walL __ 
Acute myocardial infarction. ST elevation myocardial infarction (STEM I) of 
inferolateral wall. 
Acute myocardial infarction. ST elevation myocardial infarction (STEMI) of 
inferoposterior wall. 
Acute myocardial infarction. Infarction: diaphragmatic wall (with contiguous 
portion of intraventricular septum), inferior wall (with contiguous portion of 
intraventricular septum), ST elevation myocardial infarction (STEMI) of other 
inferior wall. 
Acute myocardial infarction. Infarction: apical-lateral, basal-lateral, high lateral 
posterolateral, ST elevation myocardial infarction (STEM I) of other lateral wall. 
Acute myocardial infarction. Infarction: posterobasal, strictly posterior, ST 
elevation myocardial infarction (STEM I) of true posterior wall. 
Data Preprocessing 
The Inpatient Admission table contained 7,622 observations 
corresponding to episodes of acute myocardial infarction (AMI). These 
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observations were extracted based on ICD9 codes in table 6. However, after 
removing observations with missing values for principal procedure, 6,746 records 
are left. For these observations, average age, average length of stay, and 
average total pay were 55.14 years, 4.43 days, and $19,464 respectively (Table 
7). Age of the subjects seems to follow a bell shape distribution given that its 
mean and media, 56 years, are close together and the box-plot is fairly 
symmetric (Figure 1). However, length of stay seems to be severely skewed with 
a large standard deviation, 6.23 days, with respect to its mean. Similarly, the 
distribution of total pay has a large spread and a large difference between its 
mean and media. Peculiarly, the minimum values for both age and total pay are 
zero. These observations must be further investigated before including them in 
the statistical analysis or machine learning algorithms. It must also be noted that 
length of stay had a maximum value of 368 days, which must be investigated 
before including this observation in further analysis. In addition, most 
observations correspond to male subjects, 7,837 (73.55%). Geographically, 
most cases of AMI occurred in the southeast, 37.54%, and closely followed by 
the northeast, 34.07% (Figure 2). Moreover, most observations come from the 
insured employee, 69.82%, rather than a relative covered within the same health 
care plan (Figure 3). When stratified by occupation, most observations are 
within industries traditionally labeled as blue collar: manufacturing, 53.24%, and 
transportation, 18.07% (Figure 4). After conducting a frequency count on the 
variable RX, drug plan indicator, it is determined all these subjects have a drug 
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plan as part of their health care plan . This will help later in the analysis of their 
prescription history. 
Table 7. Summary Statistics from Inpatient Admissions Sample 
Variable Mean Std. Dev Min. 
Age 55.14 0 
Leng!h of Stay 4.43 
Total Pay $19,464.52 $25,445.68 o 
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Figure 2. Distribution of AMI cases by Region. 
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A master table containing unique id's from the inpatient admission table 
was created. This table was used to filter the outpatient service table for 
observations corresponding to those subjects who had a record of acute 
myocardial infarction in the inpatient service table . The resulting table contained 
703,793 observations with corresponding records in the inpatient service table . 
At first glance, one can notice that the ratio of this number to the number of 
subjects in the inpatient service table is 81, which implies that the average 
number of outpatient visits within these two years is 81 (Table 8, Figure 5). 
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Table 8. Number of Outpatient Records from AMI patients in the Inpatient Admission table. 
Std. Dev Lower Quartile Median Upper Quartile 
81.41 87.28 29 32 58 100 
This count has a severely skewed distribution and rather inconsistent with 
other studies about health care resource utilization. After sorting this table by id, 
service date, and provider id, many consecutive records share a single user id, 
provider id, and service date. This indicates that many of these records 
correspond to a single outpatient visit. This is consistent with the fact that the 
outpatient service table contains only one column corresponding to a 
medical/surgical procedure for payment purposes (Table 9). 
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Table 9. Sample from Outpatient Services after filtering for Inpatient Services observations 
Row SVCDATE DX1 PROC1 
number 
1 32001 02/23/2000 2859 2859 
2 04/19/2000 99213 
3 32001 946809934 07/20/2000 72981 93970 
08/08/2000 4919 
5 32001 541765934 08/28/2000 4919 4919 
09/01/2000 
7 32001 890068434 11/18/2000 4293 71010 
11/18/2000 
9 32001 890068434 41401 71010 
11 32001 890068434 11/19/2000 41400 99232 
11/19/2000 
-13 32001 890068434 11/19/2000 41400 99232 
890068434 11/19/2000 
--15 32001 890068434 11/20/2000 41400 93010 
To be able to analyze the records within the MarketScan databases, code 
descriptions were necessary for the understanding of diagnoses and procedures. 
The Center for Medicaid and Medicare Services (CMS) makes available through 
its website ICOg code tables in limited tab text files formats. These data consist 
of three hierarchical text files: diagnosis codes, procedure codes, and diagnosis 
supplement codes. For this study, both diagnosis and procedure codes are 
necessary. The tables consist of a code followed by its description, which can 
extend over several lines. The diagnosis codes vary between three and five 
digits with a decimal point after the third digit when their length is greater than 
three digits. To build a one-to-one correspondence with the codes available in 
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the MarketScan databases, the decimal point is removed and text is left-aligned. 
The procedure codes consist of three or four digits with a decimal point between 
the second and third digit. Their processing is similar to that of diagnosis code. 
In addition, procedure coding is more common with Current Procedural 
Terminology codes (CPT). These codes are five digits long and come in a tab 
delimited text file available through the American Medical Association website. 
To analyze prescription pattern within the MarketScan database, a 
description for the National Drug Codes (NDC) was necessary. This was 
downloaded via the Federal Drug Administration website. The data for these 
codes consists of three tables: manufacturer information, name and ingredient 
information, and packaging information. NDC codes from the FDA tables are ten 
digits long and come in three formats: 4-4-2, 5-3-2, and 5-4-1. The first segment 
identifies the manufacture, the second segment along with the first segment 
identifies a drug, and the third segment identifies a packaging/dose. Within the 
MarketScan database, however, NDC codes have been formatted to an eleven 
digit 5-4-2 format for computer processing. To construct a one-to-one 
correspondence to the FDA lookup table, its NDC codes must be reformatted by 
padding zeros within the different code segments and removing the hyphen 
within the code (Table 10). 
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MarketScan Format (Display) 
OXXXX -XXXX -XX 
XXXXX-OXXX-XX 
XXXXX -XXXX -OX 
Data Derivation 
Some of the outcomes of interest are not contained explicitly within the 
databases used for this study. In these cases, other features are explored with 
the aim of deriving the outcomes of interest. For this study some outcomes and 
variables of interest that must be deduced from other variables are re-infarction, 
days to re-infarction, number of prescriptions before and after AMI, number of 
outpatient visits before and after AMI, number of diagnoses during 
hospitalization, prescription history as text document, diagnosis history as text 
document, and cost for the main procedure to treat AMI. 
Reinfarction was derived by comparing the first admission per subject to 
all its following inpatient admission and checking the presence of an ICD9 code 
corresponding to acute myocardial infarction. When a following inpatient visit 
corresponded to AMI, a binary variable was created. The value of one 
corresponds to reinfarction while a value of zero corresponds to not-reinfarction. 
Days to reinfarction was computed by obtaining the difference between the first 
admission and the following admission corresponding to reinfarction. For those 
observations without reinfarction, the days to reinfarction were censored at the 
end of follow-up: December 31,2001. To obtain a true count of outpatient visits, 
the outpatient service table had to be transformed from a wide format to a long 
format (Appendix I). After conducting this transformation, a much more credible 
count is obtained (Table 11, Figure 6). The resulting count still has a skewed 
distribution; however, it is not as severe and has a much smaller standard 
deviation, which is consistent with other studies regarding health care utilization. 
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A similar algorithm was utilized to obtain prescription counts before the first 
episode of AMI and after it. 
Table 11. Number of Outpatient Visits from AMI patients in the Inpatient Admission Table. 
Mean Std. Dev Mode Lower Median Upper 
28 26.33 9 11 20 36 
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Visual and Statistical Data Exploration 
The first step in data mining is to explore the data in order to gain 
information about the possible relationships among the feature thereof [55]. 
Univariate and bivariate visualizations are informative. These techniques allow 
one to have a feeling for the properties of the features and types of association 
among variables, which in turn help define a predictive model. First, the 
univariate distributions of numerical features are investigated with box-plots and 
summary statistics (Figures 7 - 11, Table 12). It is clear that these distributions 
do not follow a bell-shape curve and are severely skewed with the exception of 
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patient's age. The summary statistics reveal that values of zero occur for 
payment. Further investigation clarify that these values correspond to subject in 
a capitated plan and must be removed when modeling total pay later in the data 
mining process. An extreme value of $479K is present in the total payment 
variable as well as a value of 90 years in the variable age occurs. 
Figure 7. Age of Patient. 
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Table 12. Summary Statistics for Continuous Variables (Overall Sample). 
Variable Std. Dev Median Min Max 
Age 55.03 7.30 56.00 8.00 90.00 
Leng!h of Stay 5.33 3.00 1.00 120.00 
Pay 23,064.57 25,653.06 16,127.50 0 478,580.32 
No. of Visits 19.10 19.92 13.00 1.00 281.00 
No. of Prescriptions 8.23 7.77 6.00 1.00 63.00 (Before) 
No. of Prescriptions (After) 12.78 8.82 11.00 1.00 101.00 
Secondly, visualizing combination of two features at time is informative 
and simple to understand. Pair of numeric variables are visually analyzed with 
scatter plots to investigate the type of relationship or association between each 
pair [55]. The scatter plot matrix below reveals that linear relationships are 
nonexistent among these variables with the exception of a mild linear association 
between the number of outpatient visits after the first case of AMI and the 
number of prescription after the first case of AMI. In particular, length of stay 
does not have a monotonic association with age of patient. 
Because this study focuses on the three main treatments of acute 
myocardial infarction, subgroup analysis can reveal further information about the 
distributions and association of the features within the dataset. The box-plots for 
the numerical distributions per treatment do not become more bell-shaped but 
remain skewed with smaller spread, though. The exception is the age of the 
patient, which becomes slightly more normalized within each treatment (Figures 
12-17). It is also interesting that the least invasive intervention, thrombolytic 
therapy, has a larger spread for length of stay than the other two treatments do. 
To explore categorical features, bar graphs are used. The bar graph 
exploring region and treatment shows a pattern of higher preference for PCI in 
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the northeastern and southeastern region. A chi-square test for treatments and 
state of hospital reveals a statically significant (p < .001) association between 
geographical area and treatment as well. Similarly, a chi-square test is 
significant between reinfarction and treatment (p<.001). In contrast, discharge 
status of alive or dead is not statistically significantly associated with treatment (p 
= .501). 
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Figure 12. Scatter Matrix of Continuous Variable. 
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Figure 13. Age of Patient per Treatment. 
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Fi!!ure 17. Number of Outpatient Visits after first episode of AMI. 
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Figure 18. Number of Outpatient Visits per Month after first episode of AMI. 
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Data Cleansing 
The observations corresponding to the maximum values for total pay by 
treatment have been removed from the sample due to the presence of numerous 
invalid diagnosis and procedure codes. Similarly, those observations with values 
of $0 and $1 for total pay have been removed . In this case, these records 
correspond to capitated plans unsuitable for analysis of financial variables. The 
three observations with largest length of stay values for thrombolytic therapy 
have also been removed due to a large number of missing values in 
demographics and invalid diagnosis codes. Since geographical location seems 
to playa role in the values of financial variables, observations with unknown 




Using text as input for classification has become very important in the past 
decade. As more professionals capture observations in the form of open-
question surveys, computer systems and word processor have made it easy to 
capture the written word digitally. This phenomenon has predominantly been 
observed in the health care industry as more doctors document their observation 
in smaller handheld computers and new nearly-universal health record systems 
are implemented [55]. 
Traditionally, in health science the presence of one or more co-morbidities 
within a record is examined by checking for the presence of one or more of the 
corresponding diagnosis codes. Then, this presence within the patient's record 
is study individually to determine its association with a disease of interest after 
adjusting for previously found risk factors [55]. This methodology is cumbersome 
to implement to study a patient's whole health record history as many more 
diagnoses are added to it year after year. With text mining, all diagnoses can be 
compiled into a document and taken into account for classification and profiling 
purposes. 
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Text Transformation for Data Mining 
One of the main issues in text mining is to represent text documents in a 
format suitable to data mining algorithms. First, features that represent a 
document must be extracted thereof. Obviously, there are thousands of features 
that could be extracted to represent a document such as each word, its 
frequency, occurrence of group of words, or occurrence of various character 
combinations. However, the best known representation of a document for data 
mining purposes is that of a vector space model [56]. In this format, each 
document is represented by N significant features Xi and the collection of 
documents is represented by a matrix in which each row represents a document. 
The first step to transform a collection of documents is to construct a 
dictionary of all the terms in the training collection of documents along with its 
document frequency. An important part of parsing the documents is the use of 
stemming and stop-words to achieve feature reduction. Stemming is the use of 
morphological variants of the words within a document. For instance, cardiac and 
cardiology have the same linguistic root cardi; hence, they are put together and 
count as one item. Similarly, stop-words is a list of words that are considered 
useless or of low-information content such as conjunctions, adverbs, and 
pronouns. Whenever one of these words is found in the stop-words table, it is 
removed from the document's feature representation. 
However, after using stemming and stop-words tables, many features 
representing a document still remain. The next step in feature reduction is to 
determine a numerical representation of these features by determining a weight 
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[56]. Mainly, there are two popular methodologies: binary and logarithmic. After 
converting the dictionary into a document-by-term table in which each cell 
represents the frequency of the term in the corresponding document, a weight 
function is applied. The binary approach assigns a value of 1 if the term appears 
in a document and a value of zero otherwise, which removes the effect of terms 
that appear more often in a document. The logarithmic approach takes the 
logarithm of the frequency of the term in a document, which decreases the effect 
of terms occurring repeatedly in a document. The last step in the feature 
extraction phase is to determine a feature's importance by term-weighting 
methods [56]. Two effective weighting methods are entropy (1) and mutual 
information (2). 
where hi is the frequency of term i in the collection of documents, m is the 
number of documents in the collection, and gij is the frequency of the term i in 
documentj. Entropy gives greater weight to terms that rarely occur in the 
collection of documents. Notice that in this formula the logarithm is taken to be 
zero when the frequency is zero. The weights are 
where P(tj) is the proportion of documents that contain term ti, P(Ck) is the 
proportion of documents that belong to category Ck, and P(ti ,Ck) is the proportion 
of documents that contain term ti and belong to category Ck. Here the logarithm 
is taken to be 0 if P(ttCk)=O or P(Ck)=O. Mutual information weighting is used 
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when a target categorical variable is of interest from the start. These weights are 
proportional to the similarity of the distribution of documents that contain the term 
to the distribution of documents that are contained in the respective category. 
In this study, the interest is to profile AMI victims according to their 
diagnosis record by IC09 codes. Therefore, after constructing the documents 
vector representation, they are submitted to an unsupervised clustering 
algorithm. Four collections of documents are explored: the diagnosis history 
before the first AMI event recorded in the database, the collection of diagnosis 
recorded during hospitalization, the prescription history before the first AMI event 
in recorded in the database, and the prescription history after the first AMI event 
recorded in the database. 
Results 
The clustering algorithm used for the collection of diagnosis before the first 
AMI record in the database was expectation-maximization (EM), which assumes 
that a model based on mixtures approximates the distribution of the data by 
fitting n cluster density functions [55]. Three clusters are found with 45%, 32%, 
and 23% of the observations respectively (Table 13). From their descriptive 
terms based on ICO-9 codes they are labeled upper respiratory infections, 
metabolic disorders and ischemic heart disease, and anemia and non-
inflammatory joint pain. One way to evaluate the homogeneity of the clusters is 
by looking at their standardized root mean squared, which measures the distance 
among the instances in the cluster (Figure 22). 
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Table 13. Diagnosis Cluster prior first AMI. 
Cluster Percentage Descriptive Terms Label 
46607807953081410907295 Upper respiratory 
7862 4659 4619 78651 78609 infections 1 45% B 
r----.,.....----.--2=5-00 .... 0- 2=5,....0 ..... 0~1 .-.2..,.50 ...... 0......,2~2 .... 7....,.2~0 ...,.2 ...... 72.,...4-- Metabolic disorders and 
4011411141394140041401 ischemic heart disease 
28594019719417231786500 Anemia and non-
3 23% 4280 7295 78609 7862 inflammatory joint pain C 
The most homogenous cluster is that corresponding to those patients who 
have been diagnosed with metabolic disorders such as diabetes and 
hyperlipidemia prior their hospitalization for AMI, followed by those who were 
diagnosed with anemia or joint pain, those who experience upper respiratory 
infections respectively. Also, there were more cases of upper respiratory 
infections than metabolic disorders and anemia accompanied with joint pain. To 
examine differences within clusters, kernel density estimation for continuous 
variable and bar graphs for categorical variables are used on outcomes of 
interest. Cluster three had the highest percentage of females among the cluster 
which is congruent with the fact that anemia is more prevalent in women. 
Figure 22. Cluster Frequency by Root Mean Squared. 
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Cluster 
Figure 24 reveals that individuals in cluster 3 tend to be slightly younger 
than those of cluster 1 and 2. Figure 25, on the other hand, shows that cluster 2 
has a higher probability of longer stays at the hospital during the first AMI event. 
Similarly, individuals in cluster 2 and 3 have a higher probability of payment 
$17,000 and $27,000 than those in cluster 1 (Figure 26). This supports the 
severity ranking from A to C where A is the highest severity and C the least. 
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The severity ranking is also validated when discharge status at the first 
episode status is examined (Figure 27). The proportion of patients who died 
during hospitalization is much lower for those in the lowest severity rank C 
compared to severity rank A and B, both of which almost identical proportions. 
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To validate this unsupervised method, the prescription history prior the 
first episode of AMI was mined and clustered. It resulted in five clusters that are 
in line with the clusters resulting from mining the patients' diagnosis history. 
Upper respiratory infections were a common theme between the two along with 
ischemic heart disease and disease related to the metabolic system such as high 
blood pressure and gout. 
Anxiety, anemia, upper respiratory infection 
Organ t ansRlant, osteoporosis, gout, menoj)ause, HBP 
5 4% Anxiety, gout, skin inflammation, upper respiratory infection, indigestion 
The cross tabulation of the clusters shows that diagnosis cluster one and 
prescription clusters two and three share many patients who were diagnosed 
with upper respiratory infections and were prescribed antibiotics to treat these 
infections (Table 15). Similarly, prescription clusters five and diagnosis cluster 
two have many subjects in common. Both prescription cluster three and 
diagnosis cluster three have a high count of subjects in their intersection. 
Table 15. Cross-tabulation of Prescription clusters and diagnosis clusters. 
Diagnosis Cluster 
1 2 3 
1 259 187 126 
8 \I) 2 181 133 74 ... s.. 
... ~ 
c., ... 
... \I) 219 166 116 b s.. 
\l)Q., 
~.E! 4 124 117 80 cS:1.,) 




A main goal of this study is to analyze resource utilization by patients 
having experienced and episode of acute myocardial infarction. In particular, 
number of outpatient visits following hospitalization, number of prescriptions 
following hospitalization, and total cost involving outpatient visits following 
hospitalization are of interest. The first two outcomes involve count data; these 
measures with highly skewed distributions are not appropriately analyzed with 
traditional methods such as ordinary least squares. Rather, count data must be 
analyzed using distributions that reflect the underlying nature of data such as 
Poisson regression [57]. By using count data models, significant relationships 
are revealed. These relationships are usually missed by ordinary least squares. 
Poisson Regression for Count Data 
The Poisson distribution is used to model the probability of a number of 
events occurring in a given time frame or space-dimension [58]. This model 
shares many similarities with traditional statistical models such as ordinary least 
squares. However, ordinary least squares transform the dependent variable, 
outcome of interest, to normalize the residuals; instead, the log transformation 
used in the Poisson distribution assures that the predicted values of the 
dependent variable will be zero or positive as its underlying nature of count data. 
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Poisson regression models the parameter IJ which represents both the 
mean and variance of the distribution. Based on the generalized linear model, 
the log function is used as the link function, so the log of IJ is modeled as a linear 
combination of the parameters. 
In this study, subjects were observed for a period of two years during 
which they experienced an episode of acute myocardial infarction at different 
points in time. Hence, the outcomes of number of outpatient visits after 
hospitalization and number of prescriptions after hospitalization are not 
appropriate to model directly. Rather, the number of prescriptions per month and 
number of outpatient visits per month following hospitalization are much 
appropriate to model in order to account for the differences from person to 
person in follow up time (Figure 28, 29). 
Figure 28. Distribution of number of visits after hospitalization. 
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Results 
Another reason for modeling the number per month is the issue of 
overdispersion where the variance is significantly greater than the mean, which is 
violation of the model assumptions. From Figure 28 and 29, the distribution of 
number of visits has a mean of 19 and variance of 300 while the distribution of 
number of visits per month has a mean of 3 and variance of 3.5, which is more in 
line with the Poisson model. 
Figure 29. Distribution of number of visits per month after hospitalization. 
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This same issue arises when modeling the number of prescriptions after 
hospitalization for acute myocardial infarction. The raw number of prescription is 
not suitable to analyze because of the differences in follow up time among 
subjects. In addition, number of prescriptions after hospitalization suffers from 
over dispersion (Figure 30). Therefore, number of prescriptions per month, 
which takes into account the differences in follow up time, will be analyzed. The 
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empirical distribution of number of prescriptions per month has a mean of 2.01 
and variance of 3.05, Figure 31, while the distribution of the number of 
prescriptions after hospitalization have a mean of 12.77 and variance 77.69 in 
violation of Poisson model. 
Figure 30. Distribution of prescription counts after hospitalization. 
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Figure 31. Distribution of prescription countsQer month after hospitalization. 
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After fitting the number of outpatient visits per month using Poisson 
regression and maximum likelihood estimation, the mode estimates are found in 
Table 24 while the model goodness of fit is found in Table 16. In contrast to most 
studies based on clinical data, age is not found to be significant. This implies 
that in practice the age of a patient does not playa role in predicting the number 
of outpatient visits as a measure of health care resource utilization. The statistics 
for goodness of fit are deviance and Pearson's chi-square with values of 0.85 
and 1.02 after dividing by degrees of freedoms respectively. The closer to one 
the deviance is, the better the fit of the model. This means the model is an 
excellent fit for explaining the relationship between the predictors and the 
outcome. 
Table 16. Analysis Of Maximum Likelihood Parameter Estimates for Visits per Month count. 
DF Estimate Standard Wald Chi- P-value 
Error Square 
Intercept 1 3.1526 0.1069 869.99 <.0001 
AGE 1 -0.0007 0.0005 2.04 0.1529 
DAYS 1 0.0155 0.0005 1006.10 <.0001 
TRT CABG 1 0.1365 0.0108 160.00 <.0001 
TRT PCI 1 0.1789 0.0098 329.89 <.0001 
Thrombolytic Therapy 0 0.0000 0.0000 
REGION Northeast Region 1 0.2180 0.1031 4.47 0.0346 
REGION North Central Region 1 -0.0867 0.1028 0.71 0.3992 
REGION South Region 1 -0.0743 0.1029 0.52 0.4703 
REGION West Region 1 0.0916 0.1035 0.78 0.3762 
REGION Unknown Region 0 0.0000 0.0000 
SEX Male 1 -0.1710 0.0080 456.80 <.0001 
SEX Female 0 0.0000 0.0000 
INDSTRY Oil & Gas Extraction, Mining 1 -0.5358 0.0741 52.34 <.0001 
INDSTRY Manufacturing, Durable Goods 1 -0.2200 0.0109 407.46 <.0001 
INDSTRY Manufacturing, Nondurable Goods 1 -0.1329 0.0146 82.45 <.0001 
INDSTRY Transportation, Communications 1 -0.1520 0.0128 141.15 <.0001 
INDSTRY Retail Trade 1 -0.5415 0.0667 65.99 <.0001 
INDSTRY Finance, Insurance, Real Estate 1 -0.2289 0.0199 132.44 <.0001 
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Table 17. Criteria For Assessing Goodness Of Fit 
Criterion DF Value Value/DF 
Deviance 4384 3719.2319 0.8484 
Pearson Chi-Square 4384 4388.0000 1.0209 
Table 18. LR Statistics For Type 3 Analysis 
Source Num DF Den DF F Value Pr> F Chi-Square Pr> ChiSq 
AGE 1 4384 0.17 0.6772 0.17 0.6772 
1 4384 67.25 <.0001 67.25 <.0001 
TRT 3 4384 11.99 <.0001 35.97 <.0001 
REGION 4 4384 20.14 <.0001 80.58 <.0001 
SEX 1 4384 37.85 <.0001 37.85 <.0001 
INDSTRY 6 4384 7.05 <.0001 42.31 <.0001 
The resulting Poisson model for the number of prescriptions after 
hospitalization is summarized in tables 28 and table 29. The deviance and 
Pearson's chi-square have values of 0.9203 and 1.002 after dividing by degrees 
of freedom respectively. Again, this model fits the data very well. The estimates 
table reveals that the explanatory variables influence the number of visits per 
month after hospitalization for acute myocardial infarction . 
Table 19.Criteria For Assessing Goodness Of Fit 
Criterion DF Value Value/DF 
Deviance 4215 3879.130 0.9203 
Pearson Chi-Square 4215 4225.000 1.002 
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Table 20. LR Statistics For Type 3 Analysis 
Source F Pr>F Chi- Pr> 
Value Square ChiSq 
AGE 1 4215 6.24 0.0125 6.24 0.0320 
TRT 3 4215 5.08 0.0016 15.25 0.2568 
REGION 3.82 0.0042 15.28 0.0039 
SEX 205.24' <.0001 
INDSTRY 6 4215 5.22 <.0001 31.35 <.0001 
Table 21. Analysis Of Maximum Likelihood Parameter Estimates. 
Parameter DF Estimate Standard Wald Chi- P-
Error Square value 
Intercept 1 2.8548 0.2423 138.81 <.0001 
AGE 1 0.0032 0.0013 6.19 0.0128 
DAYS 1 0.0138 0.0168 82.56 <.0001 
TRT CABG 1 0.0771 0.0256 9.07 0.0026 
TRT PCI 0 -0.0288 0.0246 1.36 0.2428 
TRT Thrombolytic Therapy 1 0.0000 0.000 
REGION Northeast Region 1 -0.2543 0.2312 1.21 0.2714 
REGION North Central Region 1 -0.2289 0.2299 0.99 0.3196 
REGION South Region 1 -0.1700 0.2303 
REGION West Reg!on 1 -0.2755 0.2324 
REGION Unknown Region 0 0.0000 0.0000 
SEX Male 1 -0.2872 0.0196 213.59 <.0001 
SEX Female 0 0.0000 0.0000 
INDSTRY Oil & Gas Extraction, Mining 1 -0.0377 0.1513 0.06 0.8032 
INDSTRY Manufacturing, Durable Goods 1 0.0125 0.0276 0.20 0.6510 
INDSTRY Manufacturing, Nondurable Goods 1 -0.0171 0.0375 0.21 0.6481 
INDSTRY Transportation, Communications 1 -0.0810 0.0332 5.94 0.0148 
INDSTRY Retail Trade 1 -0.1220 0.1597 0.58 0.4446 
INDSTRY Finance, Insurance, Real Estate 1 -0.1976 0.0526 14.09 0.0002 
INDSTRY Services 0 0.0000 0.0000 
On the other hand, modeling the number of outpatient visits per month 
with ordinary least squares fails to find many significance relationships among 
the predicting features and the outcome of interest. Table 31 displays the results 
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of fitting the number of outpatient visits per month after hospitalization. Clearly, 
all the covariates are found non-significant for explaining the number of 
outpatient visits. This highlights the utility of modeling count data with large 
numbers of single digit counts and overdispersion with appropriate distribution 
that match the underlying nature of the data rather than forcing a model for 
convenience. 
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Table 22. Analysis Of Ordinary Least Square Parameter Estimates. 
-Standard Pr> It I 
Error 
Intercept 2.7451 0.9276 4214 2.96 0.0031 
DAYS 0.01718 0.008152 .4214 2.11 0.0351 
<.0001 
SEX 2-Female 0 
l-Northeast Region 0.3703 
REGION 2-North Central Region -0.5850 0.8766 4214 -0.67 
3-South Region 
REGION 4-West Region -0.8129 0.8859 4214 -0.92 0.3589 
Missing/Unknown 
INDSTRY l-Oil & Gas Extraction, Mining 0.9304 0.5415 4214 1.72 0.0858 
2-Manufacturlng, Durable. Goods 0.0003 
INDSTRY 3-Manufacturlng, Nondurable -0.00083 0.1551 4214 -0.01 0.9957 
Goods 
INDSTRY 5-Retail Trade 0.1437 0.5566 4214 0.26 0.7963 
6-Flnance, Insurance, Real 
Estate 
INDSTRY 7-Services 0 
TRT Missing/Unknown 0.09609 4214 -7.82 0'.05 
TRT CABG -0.1515 0.1099 4214 -1.38 0.05 
TRT PCI -0.5940 0.05 




Predictive modeling is concerned with problems of classification and 
estimation of future outcomes [55]. The learning style is considered supervised 
learning in that instances or records with known output attributes, also known as 
dependent variables in classical statistics, and known input attributes, 
independent variables, are submitted to the learning algorithm and a correction is 
made when the predicted outcome does not match the observed outcome. In 
this study, health outcomes and health care utilization measures are of interest. 
Thus far, number of outpatient visits per month and number of prescriptions per 
month after hospitalization have been modeled with generalized linear models for 
count data. Now, the health outcomes of reinfarction after hospitalization for 
acute myocardial infarction and death during hospitalization for acute myocardial 
infarction are undertaken. Also, monthly cost for outpatient visits after 
hospitalization for AMI is modeled. 
The outcome of reinfarction was not directly observed in the database, but 
rather was derived during the data exploration phase of the project. The variable 
reinfarction was encoded in binary format with a value of 1 indicating reinfarction 
after first hospitalization and a value of zero if no reinfarction was found during 
the follow-up period. On the other hand, death during hospitalization was 
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explicitly part of the instance for each inpatient admission record within the 
attribute discharge status. The MarketScan database contains a table without 
patient service records that corresponds to each procedure performed during the 
outpatient visits. Therefore, the total outpatient costs per month was not directly 
recorded but had to be derived as well. The outpatient service table was filtered 
to contain records that corresponded to inpatient records and that took place 
after the date of discharge for the hospitalization due to AMI. 
Logistic Regression 
Reinfarction after hospitalization and death during hospitalization are 
binary outcomes which lend themselves to be modeled with a generalized linear 
model, specifically logistic regression. Logistic regression models the natural 
logarithm of the odds of an event [55]. In other words, it models the natural 
logarithm of the ratio of the expected number of times an event will occur to the 
expected number of times an event will not occur as linear combination of the 
parameters and input attributes (Equation 1). 
where Pi is the probability that Yi = 1. When this equation is solved for Pi, one 
obtains 
which is the logistic function with values between zero and one for all real 
numbers. This makes the logistic regression ideal to model probability values 
which are between zero and one respectively. Advantages to this model are that 
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the parameter estimates are simple to interpret in terms of odds ratios. 
Furthermore, it has desirable sampling properties that were discussed in chapter 
two. 
Decision Trees 
Another data mining predictive model is implemented by decision trees. In 
particular for this study, binary decision trees are implemented. A key 
characteristic of decision trees is that they only use those attributes that best 
differentiate the concepts to be learned [55]. The idea behind it is that of 
processing the data as a sequence of simple questions, and their answers 
determine what the next question is, if any. Each question is represented by a 
node that is connected to a following node, child link, in the shape of an inverted 
tree. Intrinsically, the construction of decision trees has cross-validation 
embedded in the algorithm. This means that at the starting point a subset of 
instances is selected for training and another subset is selected for testing. 
Consequently, the algorithm assesses the goodness of fit more accurately, 
possibly at each stage of the building process. At a high level, most decision 
trees are constructed with an algorithm as follows: 
1. Let K be a set of training observation. 
2. Select a variable that best differentiates the observations within K. 
3. Make a tree node represented by the selected variable: 
a. Make child nodes representing unique values or interval for the 
selected variable. 
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b. Use the child nodes to further subdivide the observation into smaller 
classes. 
4. For each class in step three: 
a. If the observations satisfy predetermined criteria, specify the 
classification for new observations following this decision path. 
b. Otherwise, there must exist at least a variable the further subdivides 
the path of the tree. In this case, return to step 2. 
The splitting rule at each node is a key element that distinguishes one 
decision tree algorithm from another. Commonly implemented rules are entropy, 
explained in chapter four, Chi-square test for classification, and F-test for 
estimates of continuous outcome variables. Another feature that defines a 
decision tree algorithm is its stopping rule. Some common stopping rules are 
minimum number of cases, a certain fraction of number of instances, achieving a 
maximum number of levels of splitting, or reaching a maximum number of nodes. 
Furthermore, conditions under which an algorithm cannot further split a node are: 
cases are all duplicates of one another, only one observation is left, and 
complete agreement of all target values. 
Decision trees have many advantages as predictive models. They tend to 
be non parametric or semi-parametric, and data does not need to specifically 
follow a probability distribution. Attributes for the model are not preselected but 
rather selected automatically by the algorithm. Data transformation is not 
necessary to feed the data to the algorithm, and mathematical monotonic 
transformations do not affect the outcome. However, despite not being affected 
97 
by outliers in the input space, decision trees algorithms are affected locally by 
outliers in the output space. 
Neural Networks 
Neural networks are another data mining method for prediction that has 
gained wider acceptance in the field of medical science and the business field of 
insurance. They were conceived on the early understanding of the human brain. 
Its building block is termed a neurode, a mathematical representation of the 
human brain's neurons [59]. These are connected in a network grid, usually 
fewer than one hundred, to imitate the functioning of the human brain, which in 
contrast contains billions thereof. The current understanding of neuron cells is 
that they receive electrical impulses from cells around them and accumulate 
these charges until a threshold is surpassed. Then, the neuron cell fires an 
electrical impulse to neighboring cells. These actions are controlled by 
biochemical processes changing over time with aging of the autonomic nervous 
system, which is in charge of the means humans learn. In contrast, artificial 
neurons connected in networks imitate these processes by numerical 
aggregation and mathematical functions, and knowledge is represented as set of 
layers of interconnected neurodes. 
Network architecture, or shape, and learning algorithm characterize most 
modern neural networks [59]. In this study only the neural network commonly 
known as the perceptron is implemented for supervised learning. At least two 
layers of neurodes are required, one for inputs and one for outputs. However, 
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the strength of neural networks lies in their ability to handle nonlinear 
relationships which are achieve by adding layers of neurodes, known as hidden 
layers, between the inputs and output(s) layers. 
The perceptron is a fully connected feed-forward neural network. Fully 
connected indicates that neurodes in one layered are connected to all neurodes 
in the next layer. Feed-forward means that input instances flow in one direction 
from the input layer towards the output layer and never backwards. In addition, 
neurodes in a common layer are never connected to each other. The 
connections between pairs of neurodes represent weights which model the 
relationships between the input neurodes and output node(s). 
A particular issue with neural networks is input and output representation. 
Input nodes must be numeric and normalized or standardized between values of 
zero and one or between values of negative one and positive one respectively. 
Basically, there are two ways to represent categorical data. One method is to 
divide the interval from zero to one into equal size subintervals corresponding to 
the various categories of an attribute. However, this methodology embeds an 
ordinal structure between categories which may not exist, such as color and 
gender. Another method uses binary representation for categories. In this case, 
the number of neurodes required to represent a feature is equal to m - 1, where 
m is the number of categories within an attribute. The transformation of 
continuous attribute is usually handled by normalization, described below: 
l\T " InputValue - Minimum Value (3) lVeWlnput = --=-----------
Maximum Value - Minimum Value 
where 
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• Newlnput is the computed value to feed the network. 
• InputValue is the original value to be converted. 
• MinimumValue is the smallest possible value for the variable. 
• MaximumValue is the largest possible value for the variable. 
Similarly, output format has the same issues. However, the solutions are 
the same. For categorical variables, binary representation tends to work best, 
and continuous data is converted back to scale by reversing the process in 
equation (3): 
Output VaIle = NeurodeOutput x (Maximum Value - Minimum Value) + Minum Value 
During the feed-forward phase, the neural network accepts input values. 
The neurodes of the input layer pass these values to the following hidden layer 
unchanged. In turn, the neurodes in the hidden layer takes in the inputs and 
weights them with the corresponding weights between each pair of neurodes and 
combines them additively. This sum becomes the input to the neurode's 
evaluation function, usually the sigmoid function (4), which outputs a value close 
to one when sufficiently excited and a value close to zero otherwise. 
f(x) = 1 ( ) (4) 
1 +exp-x 
This activity continues through each layer of neurodes until an output for 
each output node is produced; then the back-propagation phase takes place. 
During this phase, the output error is determined; that is the difference between 
the estimated value and the observed value is computed. If an error is observed, 
it is assumed that every network link associated with the output is at fault to 
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some degree. This triggers a modification in weight values beginning at the 
output layer and moving backwards through the hidden layers. The error at 
target nodes is computed as follows: 
Error{t) = {t - 0t )x II (xt ) 
where 
t = target output 
Ot = computed output 
f(Xt) = first-ordered derivative of the sigmoid function 
In turn, the error in a hidden layer neurode k is computed as follows: 
Error(k) = t2: Error(j)Wkj )f'(xk ) 
where 
ErrorU) = computed output error at node j 
Wkj = the weight between nodes k and j 
f(Xk) = the first-order derivative of the sigmoid function 
Xk = the input to the sigmoid function at node k 
Finally, the appropriate weight correction at each node during the back-
propagation is computed as follows: 
Where 
Wkj (new) = Wkj + r x Error{j) x Ok 
Wjk(new) = the new weigh between nodes j and k 
Wjk = the current weight between nodes j and k 
r = learning rate 
ErrorU) = computed error at node j 
Ok = output of node k 
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Feature Selection and Sampling 
In this section of the study, the goal is to produce effective predictive 
models for reinfarction and monthly outpatient costs. A key element is building 
predictive models is feature selection. One crude method is to start by using the 
chi-square statistic; another is by fitting a decision tree and using the resulting 
variables worth, which is equivalent to the sum of square errors [55]. Figure 31 
displays the results for the chi-square. Diagnosis related group, which is a code 
system developed by Centers for Medicare & Medicaid Services for 
reimbursement purposes, is highly associated with reinfarction. It is closely 
followed by admission type. Much less associated, by this measure, are 
employee's classification (Le. full-time, union, etc .. ), industry, and treatment. 
However, industry will not be used as some observations correspond to 
employee's dependents and a different approach should be followed. It is worth 
noticing is that age and gender are not very associated with the outcome, in 
contrast to most clinical studies. Three predictive models are developed for the 
outcome of reinfarction: logistic regression, decision tree, and multilayer 
perceptron. 
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Another issue in predicting reinfarction is its rare occurrence. Most 
predictive models are very sensitive to rare occurrences [55]. To circumvent this 
weakness, careful sampling must take place. In this case less than eight percent 
of the instances have a positive indicator for reinfarction. Therefore, all these 
instances must be included in the sample for fitting and validation (n=366). 
Another sample of 366 instances with a negative indicator for reinfarction must 
be taken . Since AMI treatment is of interest, this random sample will be stratified 
by treatment so that it remains representative. Finally, these two samples are 
merged and submitted to the algorithms (n=732). 
Results 
The decision tree implemented is a binary tree. Its splitting rules are 
based on entropy for categorical variables and minimum variance for continuous 
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data with a threshold of 0.2. It resulted on two splits. The first split was based on 
diagnosis related group, and the second on length of stay during hospitalization 
for AMI. The resulting English Rules that characterized the resulting tree are in 
Table 23. Its misclassification rate for the outcome of reinfarction was 0.35 in the 
training set and 0.39 in the validation set. This means that the tree generalizes 
well. 
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Table 23. Decision Tree - English Rules. 
Node 3 
if Diagnosis Related Group IS ONE OF: 122 or MISSING 
then 
Tree Node Identifier = 3 
Number of Observations = 58 
Predicted: REINFARCTION=l = 0.95 
Predicted: REINFARCTION=O = 0.05 
Node4 
if Length of Stay < 2.5 
AND Diagnosis Related Group IS ONE OF: 116,106,516,110,517,112,107,109,104 
then 
Tree Node Identifier = 4 
Number of Observations = 154 
Predicted: REINFARCTJON=l = 0.58 
Predicted: REINFARCTJON=O = 0.42 
NodeS 
if Length of Stay >= 2.5 or MISSING 
AND Diagnosis Related Group IS ONE OF: 116,106,516,110,517,112,107,109,104 
then 
Tree Node Identifier = 5 
Number of Observations = 300 
Predicted: REINFARCTION=l = 0.37 
Predicted: REINFARCTION=O = 0.63 
The logistic regression model was first fit with stepwise forward selection, 
but it did not find any significant variables at the 0.05 significance level. 
Backward selection had the same results. Thus, the model was fitted the 
variables of importance from the decision tree: diagnosis related group and 
length of stay. In addition, AMI treatment and gender were included. However, 
none of these variables were found to have a significant effect on the outcome of 
interest: reinfarction . This is congruent to the findings of stepwise-forward 
selection. Table 24 displays the results from fitting this model. This model ha.d a 
misclassification rate of 0.37 in the training set and 0.45 in the validation set. 
This indicates that the logistic regression model does not generalize well. 
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The multilayer perceptron architecture consisted of a layer of inputs for 
diagnosis related codes, length of stay, treatment, number of visits per month 
before and after hospitalization, age, and number of prescriptions before and 
after hospitalization. In addition, a hidden layer with three neurodes was 
implemented between the input layer and the output layer. The activation 
function for hidden layer nodes was the logistic function. Since the outcome was 
dichotomous, the binomial activation function was used on output nodes. The 
resulting neural network had a misclassification rate of 0.221 in the training set 
and 0.385 in the validation set. This may indicate that over fitting may have 
occurred; however, the neural network generalizes well when compared to the 
other two models (Table 25). 
Table 25. Misc1assification Rates for Predictive Models of Reinfarction. 











During data exploration, it was found that outpatient costs per month after 
hospitalizations were not bell-shaped distributed but rather skewed. For 
modeling purposes, a data transformation is applied. The natural log is applied 
to the outpatient costs per month and clearly a bell-shape distribution is achieved 
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(Figure 34). After determining correlations, it is found that total pay during 
hospitalization , length of stay during hospitalization , and age are positively 
correlated to outpatient costs (Figure 35). 
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The same strategy for feature selection is implemented for modeling 
outpatient costs per month after hospitalization. That is, a tree is implemented , 
and the features selected by it are used in implementing a generalized linear 
model and a neural net. The features selected by the decision tree in order of 
importance are total payment during hospitalization for AMI, diagnosis related 
code, monthly number of prescriptions prior to hospitalization, length of stay 
during hospitalization, and gender. A stepwise-forward selection is also 
implemented resulting in the selection of four common features with the decision 
tree: diagnosis related group, monthly number of visits prior to hospitalization, 
total pay during hospitalization, and gender (Table 26). In addition , geographical 
region was found significant while the decision tree did not find this feature 
important. The multilayer perceptron was implemented with a single hidden layer 
consisting of four neurodes. The activation function for hidden neurons was the 
logistic function while the activation function for the output layer was linear 
function. The criterion for model selection is the root mean square error (Table 
27). Clearly, the multilayer perceptron was superior to the generalized linear 
model with a mean square error of 1.29. It is important to observe that both 
model generalized well in the validation set, though. 
Table 26. Analysis of Effects for Linear Regression 
Effect DF Sum of Squares FValue P-value 
DRG 29 306.43 5.93 < .0001 
Region 4 50.71 7.21 < .0001 
Sex 1 10.78 6.06 .0139 
Total Pay 1 97.29 54.68 < .0001 
Prior Visits per Month 1 131.98 74.17 < .0001 
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Table 27. Model Selection Criterion for Predictive Models of Outpatient Costs. 
Model Mean Square Error (Training Set) Mean Square Error (Validation Set) 
Linear Regression 1.34 1.33 
Neural Network 1.29 1.28 
Figure 36. Enterprise Miner Predictive Modeling Workflow. 
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Thus far, the data set features have been explored for predictive purposes 
in cases of acute myocardial infarction. In this section, the aim is to explore the 
effectiveness for the various treatments for acute myocardial infarction when due 
to coronary occlusion. A statistically powerful method to evaluate effectiveness 
for treatment is survival analysis, which involves studying whether or not an 
event of interest occurs and when the event of interest occurs. In this case, the 
event of interest is reinfarction after hospital discharge for treatment of 
myocardial infarction. This is possible with this data set because the date of 
discharge and date of admission are readily available in the inpatient admission 
table. To identify the occurrence of an event of interest, the diagnosis within 
each record are checked against the criteria of interest, in this case an ICOg 
code corresponding to acute myocardial infarction. 
There is a characteristic of this data that makes it appropriate for an 
application of survival analysis in studying the effectiveness of a treatment for 
myocardial infarction. All subjects are followed for a period of two years only. 
This means that many of them did not have a reinfarction during this time but 
could have had one after this time. In turn, this means that such observations 
are censored at the end of the observational period. Logistic regression is not 
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appropriate because it does not take into account how the chances of 
experiencing a reinfarction changes over time while ordinary least square 
regression cannot take into account censored observations without losing 
statistical power. 
Survival Analysis: Cox Proportional Hazards Models 
The specific survival analysis model implemented in this research is that 
of Cox proportional hazards. It allows for the inclusion of subjects starting 
observation at different times such as this scenario as not all individual 
experienced an episode of infarction the same day. This method models the 
hazard function, which can be thought of as the number of events per interval of 
time. 
h{t) = lim Pr{t s T < t + MIT ~ t} (1) 
M-O M 
This function is modeled in the following form: 
The function in (2) says that for an individual i at time t, the hazard is the 
product of a baseline function Ao(t), a nonnegative unspecified function, and the 
natural exponential function of a linear combination of k variables. In this case, 
AO(t) is regarded as the hazard function for an individual with all variables taking 
values of zero. The coefficients ~1 through ~k are estimated using the method of 
partial likelihood. This consists of writing the product of the likelihoods for all the 
events that are observed rather than writing the product of all the likelihoods for 
all individuals in the sample: 
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PL = fr n efJx; (3) 
tf ~ Y..efJxj 4. I] 
]-1 
where i represents the individual observation, i = {1, ... , n}, ti is the time of 
event or censoring time for observation i, 5i is 1 if ti is uncensored or if ti is 
censored, Xi is a vector of k covariate values, and ~ is a vector of coefficients. 
The coefficients are finally estimated by the Maximum likelihood method 
explained in chapter 2. 
The covariates of interest analyzed for effectiveness of treatments are 
treatment itself, gender, age, and length of stay during hospitalization. Table 27 
contains the results after fitting the Cox proportional hazards model to the 
MarketScan data set. Both treatment and length of stay during hospitalization 
have a significant effect on time to reinfarction while the other covariates were 
found to be statistically insignificant. One can see that the hazard of reinfarction 
for patients treated with PCI is only 82% that of the patients treated with 
thrombolytic therapy, and the hazard of reinfarction for patients treated with 
CABG is 58% of that of patients treated with thrombolytic therapy. Similarly, it is 
evident in Figure 37 that the three groups have distinct survival curves with 
CABG treated patients having a longer time to reinfarction compared to PCI and 
thrombolytic therapy treated patients. 
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Table 27. Analysis of Cox Proportional Hazard Estimates 
Parameter DF Parameter Standard Chi-Square Pr> ChiSq Hazard 
Estimate Error Ratio 
TRT CABG 1 -0.54089 0.19425 7.7533 0.0054 0.582 
TRT PCI 1 -0.19432 0.12326 2.4854 0.1149 0.823 
AGE 1 0.00609 0.00778 0.6121 0.4340 1.006 
SEX 1 1 -0.05063 0.12667 0.1597 0.6894 0.951 
REGION 1 1 -0.36232 1.00969 0.1288 0.7197 0.696 
REGION 2 1 -0.65314 1.00512 0.4223 0.5158 0.520 
REGION 3 1 -0.38735 1.00488 0.1486 0.6999 0.679 
REGION 4 1 -0.41520 1.01396 0.1677 0.6822 0.660 
Length of 1 -0.07179 0.02315 9.6175 0.0019 0.931 
Stay 
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During the last decade many interventional cardiolog ists and public health 
administrators have promoted the idea of more aggressive interventions in 
treating acute myocardial infarction with the aim of reducing mortality and rates of 
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reinfarction. One of the objectives of this study is to determine the cost-
effectiveness of percutaneous coronary intervention and coronary artery bypass 
graft surgery as more aggressive alternatives to thrombolytic therapy. Cost-
effectiveness analysis is better defined in Cost-Effectiveness in Health and 
Medicine [60] as 
"Cost-effectiveness analysis is a method designed to assess 
the comparative impacts of expenditures on different health 
interventions ... based on the premise that 'for any given level of 
resources available, society wishes to maximize the total aggregate 
health benefits conferred.' The central measure used in cost-
effectiveness analysis is the cost-effectiveness ratio. Implicit in the 
cost-effectiveness ratio is a comparison between alternatives. The 
cost-effectiveness ratio for comparing the two alternatives is the 
difference in their costs divided by the difference in their 
effectiveness, or CIE. " 
In this part of the study, effectiveness is measured in number of deaths 
averted within hospitalization since patient's id in the database cannot be 
matched to death certificates therefore making assertion of death out of a 
hospitalization record impossible. Examination of benefits and costs of the three 
distinct interventions for acute myocardial infarction is based on the model 
constructed using the data mining method of sequence rules analysis explained 
in chapter two. 
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To apply this data mining technique to the MarketScan data set, the 
inpatient admission records were converted from a wide format to a long format 
(Appendix J). As described previously, each record in this table contains up to 
fifteen medical and surgical procedures related to the hospital admission, which 
is a wide format. To obtain the long format, the data set was transposed. Each 
record in the resulting data set consisted of a patient's id and a procedure in 
order of execution, which is a long format. The a priori algorithm requires a chain 
size and minimum confidence level and support level. The chain size consists of 
the number of items, procedures in this case, that can be included in a sequence; 
the confidence level represents the empirical conditional probability of one 
procedure being performed given that another procedure has been performed 
while the support level denotes the percent of all transactions, inpatient 
admissions, that contain a given sequence. 
As explained in chapter one, many procedures are performed during a 
diagnosis of acute myocardial infarction, such as electrocardiograms and other 
lab tests. These are standard procedures, which are expected to have a high 
support and confidence level within the data set. However, the structure of the 
model for cost-effectiveness seeks to describe the performance of procedures 
that deviate from the intended procedure used to treat a patient experiencing an 
acute myocardial infarction. For instance, sometimes the administration of 
thrombolytic agents is unsuccessful in treating a thrombus and emergency 
percutaneous coronary angioplasty must be performed to save the patient's life. 
Therefore, both the support and confidence level were set to 1 % while the 
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maximum chain size was set to three. In addition, all CPT and IC09 codes for 
PCI, CABG, and Thrombolytic therapy were compressed into one code for each 
procedure respectively in order to obtain more meaningful association rules. 
Table 28. Derived Sequences 
Sequence 
Thrombolytic Therapy -+ Rescue PCI 
PCI -+ Rescue CABG 
Thrombolytic Therapy, Rescue PCI -+ Alive at 
discharge 






Given the resulting sequences and their respective confidence levels, a 
model in the form of a decision probability tree is constructed (Figure 38). Cost-
effectiveness framework dictates that the decision tree must be binary at each 
decision node. This means that the probabilities at each decision node are 
complementary. That is, they add up to one. Following this criteria , subsets from 
the inpatient admission table were created to match the events described by the 
derived sequences. From these subsets, event probabilities were estimated from 
the observed frequencies and event costs were estimated by respective events' 
sample means (Table 29,30). 
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Fi ure 38. Cost-Effectiveness Model 
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Table 29. Cost-Effectiveness Model Probabilities 
Even~t __ _ 
Success given Thrombolytic Therapy 
Failure given Thrombolytic TherapJ'.: 
Rescue PCI given Failed Thrombolytic Therapy 
Mortality given Failed ThrombolYlic Therapy 
Failure given Rescue PCI 
Success given Rescue PCI 
Success given PCI 
Failure given PCI 
Rescue CABG given Failed PCI 
Mortality given Failed PCI 
Failure given Rescue CABG 
Success given Rescue CABG 
Success given CABG 
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To evaluate the cost-effectiveness of these three alternative treatments for 
acute myocardial infarction the decision model (Figure 38) had to be rolled back. 
That is, the joint probability of each outcome (e.g ., Rescue PCI given 
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Thrombolytic Therapy) was multiplied by the utility of the outcome (probability of 
alive) and summed over all outcomes; these values were then stratified by 
alternatives. The incremental cost-effectiveness then was evaluated by dividing 
the incremental costs by the incremental effectiveness. The following expression 
computes the effectiveness thrombolytic therapy: 
Effectiveness = P(rescue PCI I Throbolytic therapy) ' P(alive I rescue PCI ) + 
P(no rescue PCI I thrombolytic therapy) ' P(alive I no rescue PCl) 
This represents the long-term proportion of saved lives while the following 
expression computes the cost-effectiveness ratio between therapy A and therapy 
B: 
C / E = Expected Cost for therapy A - Expected Cost f or therapy B 
Effectiveness for therapy A - Effectiveness for therapy B 
Thus, to analyze the results of the model , a table with the various expected costs 
and effectiveness, in descending order, for each treatment is constructed (Table 
31 ). 
Table 31. Cost-effectiveness for Treatment for AMI 

















From Table 31 , it is evident that it costs $121,569 per life saved were PCI 
implemented over thrombolytic therapy in the long term. On the other hand, it 
would save $41,081 per life saved were PCI implemented over CABG in the long 
term. Clearly, percutaneous coronary intervention is more cost-effective than 
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coronary artery bypass graft surgery. In contrast, it is not clear whether 
percutaneous coronary intervention is more cost-effective than thrombolytic 
therapy. This would be possible once a benchmark is set. However, the United 
States of America does not have such benchmark, and such decision rests in the 




This study implemented a data mining framework to determine and asses 
the main treatments for acute myocardial infarction. With the help of literature 
review, it was determined that thrombolytic therapy, percutaneous coronary 
intervention (angioplasty), and coronary artery bypass graft surgery were the 
three main treatments for victims of sudden heart attacks. Traditionally, health 
outcomes and utilization have been studied under the framework of classical 
statistics, which makes great assumptions about the distributions of the variables 
under study. Under ideal circumstances, such as clinical trials, most of these 
assumptions are satisfied. However, in day-to-day practice most of these 
assumptions fail to hold true. Exploratory data mining revealed that the 
distributions of most continuous outcomes did not follow a Gaussian distribution 
but rather severely skewed distributions, which do not conform to the 
assumptions of classical statistical models. Consequently, the need for a 
different analytical framework such as data mining was required. 
The assessment was based on determining a profile of patients 
undergoing an episode of acute myocardial infarction, determine resource 
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utilization by each treatment, and creating a model that predicts each treatment 
resource utilization and cost for a distinct subject. 
Text Mining and unsupervised clustering defined feature-based profiles 
that characterized subjects who underwent different treatments for acute 
myocardial infarction. Likewise, with the implementation of text mining along with 
clustering analysis prescription-based profiles were created which were 
associated with corresponding diagnosis clusters. This was demonstrated with 
the use of kernel densities, a nonparametric statistical method, by estimating the 
empirical distributions of outcomes by clusters of diagnosis and severity. 
Decision trees, a data mining method, were used not only for their 
predictive modeling value but also established the most logical thresholds for 
variables; and they defined a hierarchy of features selected as inputs for other 
predictive models. It was evident that traditional features selection such as 
stepwise forward selection did not perform as well when used in non-
homogenous data sets. In addition, it was demonstrated the importance of 
carefully considering the nature of the data being study in the use of appropriate 
statistical models for count data. The use of a Poisson model, a model for 
distribution of counts, was shown to be empirically superior to ordinary least 
squares in determining covariates that influence the distribution of the specific 
outcome. 
The role of neural networks in building superior predictive models was 
confirmed as more appropriate in establishing higher predictive power when real 
world data is used. However, neural networks do have some drawbacks that 
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were clearly exposed. The mathematical complexity renders the model 
somewhat difficult to interpret for most stakeholders. In contrast to traditional 
regression models that define a relationships between outcome and an input 
based on the significance of corresponding coefficients and often linear 
associations which fail to hold in the medical world. 
Finally, contribution to the field of applied mathematics and public health 
was achieved by carefully transforming wide-format records to long-format and 
implementing sequence analysis on them. This resulted in the determination of 
the sequence of treatment of acute myocardial infarction. This, in turn, was used 
to construct a probability tree that defined the basis for a cost-effectiveness 
analysis that compared treatments for acute myocardial infarction. The semi-
parametric model known as Cox Proportional Hazards was implemented to 
evaluate the effectiveness of these treatments within a survival analysis 
methodology. It found that thrombolytic therapy had superior outcomes when 
compared to angioplasty and open-heart surgery. These finding are similar to 
those in studies contemporaneous to the data set. However, it must be noted 
that literature review of more recent studies have shown that as percutaneous 
coronary intervention has been refined, it has also become more effective in 
treating episodes of sudden heart attacks. 
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Inpatient Admissions Table· Variables 
Name Type Label Length 
ADM DATE Numeric Date of Admission 5 
ADMTYP Character Admission Type 
AGE Numeric Age of Patient 4 
AGEGRP Character Age Group 
CASEID Numeric Case and Services Link 7 
DATATYP Numeric Data Type 4 
DAYS Numeric Length of Stay 5 
DOBYR Numeric Patient Birth Year 4 
DRG Numeric Diagnosis Related Group 4 
DSTATUS Character Discharge Status 2 
DX1 Character Diagnosis 1 5 
DX10 Character Diagnosis 10 5 
DX11 Character Diagnosis 11 5 
DX12 Character Diagnosis 12 5 
DX13 Character Diagnosis 13 5 
DX14 Character Diagnosis 14 5 
DX15 Character Diagnosis 15 5 
DX2 Character Diagnosis 2 5 
DX3 Character Diagnosis 3 5 
DX4 Character Diagnosis 4 5 
DX5 Character Diagnosis 5 5 
DX6 Character Diagnosis 6 5 
DX7 Character Diagnosis 7 5 
DX8 Character Diagnosis 8 5 
DX9 Character Diagnosis 9 5 
EECLASS Character Employee Classification 
EESTATU Character Employment Status 1 
EGEOLOC Character Geographic Location Employee 2 
EIDFLAG Character Enrollee ID Derivation Flag 
EMPCTY Numeric County Employee 5 
EMPREL Character Relation to Employee 1 
EMPZIP Numeric Zipcode Employee 3 Digit 4 
ENRFLAG Character Enrollment Flag 1 
ENROLID Numeric Enrollee ID 7 
EPISODE Numeric 3 
HOSPCTY Numeric County Hospital 5 
HOSPPAY Numeric Payments: Hospital 7 
HOSPZIP Numeric Zipcode Hospital 3 Digit 4 
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INDSTRY Character Industry 
LASTADM Numeric Days from Prior Discharge 5 
MDC Character Major Diagnostic Category 2 
MSA Numeric Metropolitan Statistical Area 5 
NEXTADM Numeric Days to Next Admission 5 
PATFLAG Character Patient Indistinct Flag 
PATID Numeric Patient ID 7 
PDX Character Diagnosis Principal 5 
PHYFLAG Character Physician Specialty Coding Flag 
PHYSID Numeric Physician I D 7 
PHYSPAY Numeric Payments: Physician 7 
PLAN KEY Numeric Benefit Plan Link 5 
PLANTYP Numeric Plan Indicator 4 
PPROC Character Procedure Principal 5 
PROC1 Character Procedure Code 1 5 
PROC10 Character Procedure 10 5 
PROC11 Character Procedure 11 5 
PROC12 Character Procedure 12 5 
PROC13 Character Procedure 13 5 
PROC14 Character Procedure 14 5 
PROC15 Character Procedure 15 5 
PROC2 Character Procedure 2 5 
PROC3 Character Procedure 3 5 
PROC4 Character Procedure 4 5 
PROC5 Character Procedure 5 5 
PROC6 Character Procedure 6 5 
PROC7 Character Procedure 7 5 
PROC8 Character Procedure 8 5 
PROC9 Character Procedure 9 5 
REGION Character Region 1 
RX Character Cohort Drug Indicator 1 
SEQNUM Numeric Sequence Number 7 
SEX Character Gender of Patient 1 
STATE Character State of Hospital 2 
TOTNET Numeric Payments: Net (Case) 7 
TOTPAY Numeric Payments: Total (Case) 7 
TRIMLOS Numeric Trim Flag Length of Stay 5 
TRIMPDM Numeric Trim Flag Per Diem 5 
UNIHOSP Numeric Hospital ID Number (MDST) 7 






MarketScan National Weight Link 





MARKETSCAN DATA: INPATIENT SERVICES TABLE VARIABLES 
DESCRIPTION 
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Inpatient Services Table - Variables 
Name Type Label Length 
ADMDATE Numeric Date of Admission 5 
ADMTYP Character Admission Type 1 
AGE Numeric Age of Patient 4 
AGEGRP Character Age Group 1 
CASEID Numeric Case and Services Link 7 
COB Numeric COB and Other Savings 7 
COPAY Numeric Copayment 7 
DATATYP Numeric Data Type 4 
DEDUCT Numeric Deductible 7 
DOBYR Numeric Patient Birth Year 4 
DRG Numeric Diagnosis Related Group 4 
DSTATUS Character Discharge Status 2 
DX1 Character Diagnosis 1 5 
DX2 Character Diagnosis 2 5 
DX3 Character Diagnosis 3 5 
DX4 Character Diagnosis 4 5 
DX5 Character Diagnosis 5 5 
EECLASS Character Employee Classification 1 
EESTATU Character Employment Status 1 
EGEOLOC Character Geographic Location Employee 2 
EIDFLAG Character Enrollee ID Derivation Flag 
EMPCTY Numeric County Employee 5 
EMPREL Character Relation to Employee 1 
EMPZIP Numeric Zipcode Employee 3 Digit 4 
ENRFLAG Character Enrollment Flag 
ENROLID Numeric Enrollee ID 7 
HOSPCTY Numeric County Hospital 5 
HOSPZIP Numeric Zipcode Hospital 3 Digit 4 
INDSTRY Character Industry 
MDC Character Major Diagnostic Category 2 
MSA Numeric Metropolitan Statistical Area 5 
NETPAY Numeric Payments Net 7 
PATFLAG Character Patient Indistinct Flag 1 
PATID Numeric Patient ID 7 
PAY Numeric Payment 7 
PDDATE Numeric Date Claim Paid 5 
PDX Character Diagnosis Principal 5 
PHYFLAG Character PhysiCian Specialty Coding Flag 1 
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PLAN KEY Numeric Benefit Plan Link 5 
PLANTYP Numeric Plan Indicator 4 
PPROC Character Procedure Principal 5 
PROC1 Character Procedure Code 1 5 
PROCMOD Character Procedure Code Modifier 2 
PROCTYP Character Procedure Code Type 1 
PROVCTY Numeric County Provider 5 
PROVID Numeric Provider ID 7 
PROVZIP Numeric Zipcode Provider 3 Digit 4 
QTY Numeric Quantity of Services 5 
RECFLAG Character Record Flag 1 
REGION Character Region 1 
REVCODE Character Revenue Code 3 
RX Character Cohort Drug Indicator 
SEQNUM Numeric Sequence Number 7 
SEX Character Gender of Patient 1 
STDPLAC Numeric Place of Service 4 
STDPROV Numeric Provider Type 4 
STDSVC Numeric Service Type 4 
SVCDATE Numeric Date Service Incurred 5 
TOTPAY Numeric Payments: Total (Case) 7 
TSVCDAT Numeric Date Service Ending 5 
UNIHOSP Numeric Hospital ID Number (MDST) 7 
VERSION Character Version 2 
WGTKEY Numeric MarketScan National Weight Link 4 
YEAR Numeric Date Year Incurred 4 
136 
APPENDIX C 
MARKETSCAN DATA: OUTPATIENT SERVICES TABLE VARIABLES 
DESCRIPTION 
137 
Outpatient Services Table· Variables 
Name Type Label Length 
AGE Numeric Age of Patient 4 
AGEGRP Character Age Group 1 
COB Numeric COB and Other Savings 5 
COPAY Numeric Co payment 5 
DATATYP Numeric Data Type 4 
DEDUCT Numeric Deductible 5 
DOBYR Numeric Patient Birth Year 4 
DX1 Character Diagnosis 1 5 
DX2 Character Diagnosis 2 5 
DX3 Character Diagnosis 3 5 
DX4 Character Diagnosis 4 5 
DX5 Character Diagnosis 5 5 
EECLASS Character Employee Classification 1 
EESTATU Character Employment Status 1 
EGEOLOC Character Geographic Location Employee 2 
EIDFLAG Character Enrollee ID Derivation Flag 
EMPCTY Numeric County Employee 5 
EMPREL Character Relation to Employee 1 
EMPZIP Numeric Zipcode Employee 3 Digit 4 
ENRFLAG Character Enrollment Flag 
ENROLID Numeric Enrollee ID 7 
INDSTRY Character Industry 
MDC Character Major Diagnostic Category 2 
MSA Numeric Metropolitan Statistical Area 5 
NETPAY Numeric Payments Net 5 
PATFLAG Character Patient Indistinct Flag 
PATID Numeric Patient ID 7 
PAY Numeric Payment 5 
PDDATE Numeric Date Claim Paid 5 
PHYFLAG Character Physician Specialty Coding Flag 
PLAN KEY Numeric Benefit Plan Link 5 
PLANTYP Numeric Plan Indicator 4 
PROC1 Character Procedure Code 1 5 
PROCGRP Numeric Procedure Code Group 4 
PROCMOD Character Procedure Code Modifier 2 
PROCTYP Character Procedure Code Type 1 
PROVCTY Numeric County Provider 5 
PROVID Numeric Provider ID 7 
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PROVZIP Numeric Zipcode Provider 3 Digit 4 
QTY Numeric Quantity of Services 5 
RECFLAG Character Record Flag 1 
REGION Character Region 1 
REVCODE Character Revenue Code 3 
RX Character Cohort Drug Indicator 
SEQNUM Numeric Sequence Number 7 
SEX Character Gender of Patient 1 
STDPLAC Numeric Place of Service 4 
STDPROV Numeric Provider Type 4 
STDSVC Numeric Service Type 4 
SVCDATE Numeric Date Service Incurred 5 
TG Character Treatment Group 2 
VERSION Character Version 2 
WGTKEY Numeric MarketScan National Weight Link 4 
YEAR Numeric Date Year Incurred 4 
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Outpatient Pharmaceutical Claims Table· Variables 
Name Type Label Length 
AGE Numeric Age of Patient 4 
AGEGRP Character Age Group 
AWP Numeric Average Wholesale Price 7 
COB Numeric COB and Other Savings 7 
COPAY Numeric Co payment 7 
DATATYP Numeric Data Type 4 
DAWIND Character Dispense as Written Indicator 2 
DAYSUPP Numeric Days Supply 5 
DEACLAS Character DEA Classification 
DEDUCT Numeric Deductible 7 
DISPFEE Numeric Dispensing Fee 7 
DOBYR Numeric Patient Birth Year 4 
EECLASS Character Employee Classification 1 
EESTATU Character Employment Status 1 
EGEOLOC Character Geographic Location Employee 2 
EIDFLAG Character Enrollee 10 Derivation Flag 
EMPCTY Numeric County Employee 5 
EMPREL Character Relation to Employee 1 
EMPZIP Numeric Zipcode Employee 3 Digit 4 
ENRFLAG Character Enrollment Flag 
ENROLID Numeric Enrollee 10 7 
GENERID Numeric Generic Product 10 7 
GENIND Character Generic Indicator 1 
INDSTRY Character Industry 1 
INGCOST Numeric Ingredient Cost 7 
MAINTIN Character Maintenance Indicator 
METQTY Numeric Metric Quantity 5 
MSA Numeric Metropolitan Statistical Area 5 
NDCNUM Character National Drug Code 11 
NETPAY Numeric Payments Net 7 
PATFLAG Character Patient Indistinct Flag 
PATIO Numeric Patient 10 7 
PAY Numeric Payment 7 
PDDATE Numeric Date Claim Paid 5 
PHARMID Numeric Pharmacy 10 7 
PHCLASS Numeric Pharmacy Class Code 4 
PHRMCTY Numeric County Provider 5 
PHRMZIP Numeric Zipcode Provider 3 Digit 4 
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PHYFLAG Character Physician Specialty Coding Flag 
PLAN KEY Numeric Benefit Plan Link 5 
PLANTYP Numeric Plan Indicator 4 
QTY Numeric Quantity of Services 5 
REFILL Numeric Refill Number 4 
REGION Character Region 
SALETAX Numeric Sales Tax 7 
SEQNUM Numeric Sequence Number 7 
SEX Character Gender of Patient 1 
SVCDATE Numeric Date Service Incurred 5 
THERCLS Numeric Therapeutic Class 4 
THERGRP Character Therapeutic Group 2 
VERSION Character Version 2 
YEAR Numeric Date Year Incurred 4 
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MARKETSCAN DATA: INPATIENT ADMISSION SAMPLE 
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R E A AA D 
0 N D G X 
w R M DE 1 
0 D 
L A M 
n I T 






1 36173 02/10/ 2 5 411 
2401 2000 8 1 
2 36182 05/16/ 2 6 410 
5601 2000 0 71 
3 36182 OS/26/ 1 6 410 
5601 2000 0 71 
4 36186 12/27/ 2 5 411 
6001 2000 4 1 
5 36192 04/15/ 2 5 410 
7501 2000 3 71 
6 36192 04/16/ 1 5 410 
7501 2000 3 41 
7 16334 03/24/ 1 6 414 
7001 2000 0 01 
8 16302 03/07/ 2 5 410 
9701 2000 4 01 
9 16302 03/10/ 2 5 410 
9701 2000 4 01 
1 16302 03/12/ 1 5 410 
o 9701 2000 4 01 
1 16302 03/21/ 1 5 414 
1 9701 2000 4 01 
1 36097 02/15/ 2 6 410 
2 9701 2000 4 42 
D D D 
X X X 
1 1 1 
0 1 2 
1 36101 06/02/ 1 4 410 998 402 410 
3 6601 2000 2 41 11 10 90 
1 36185 02/09/ 2 6 410 





1 36196 11/11/ 1 6 410 786 V45 V58 250 
5 5004 2000 2 41 50 81 49 90 
1 36225 04/24/ 1 5 410 276 411 vn 410 
6 2201 2000 2 71 6 1 82 90 
1 36225 07/17/ 2 5 410 






D D D D D D 
X X X X X X 
2 3 4 5 6 7 
410 441 414 578 715 786 
00 01 01 1 90 51 
411 436 414 
1 01 
427 436 414 250 411 
1 01 90 1 
410 786 401 
92 59 9 
411 414 414 
1 01 9 
410 786 414 414 
90 50 00 01 
410 413 414 786 411 V45 
30 9 00 52 1 81 
410 428 786 427 
11 0 52 89 
410 410 428 
00 11 0 
410 410 511 414 428 411 




410 428 511 786 786 995 411 42 
11 0 8 09 50 2 1 94 
410 410 427 348 
41 90 5 1 
410 786 414 414 423 V58 518 51 
11 50 00 01 9 49 89 19 
411 414 428 414 V45 
1 00 0 01 81 
410 486 414 793 414 414 231 51 
71 01 1 00 9 8 19 
410 414 786 518 428 429 518 51 
11 01 50 3 0 2 89 80 
410 410 518 414 414 V45 
71 90 89 9 02 81 















































R E A AA D D D D D DD D D D D D D D D E E E E 
0 N D G X X X X X X X X X X X X X G 
w R M DE 1 1 1 1 1 XX 2 3 4 5 6 7 8 9 E EEl 
0 D 0 1 2 3 OD 
L A M 11 CS 
n I T L F 




e P ST 
r G 
SU 
1 36233 02/19/ 2 4 410 401 915 1 
8 9702 2000 1 41 9 2 
1 36233 02/24/ 1 4 410 414 915 1 
9 9702 2000 1 41 01 2 
2 36243 11/16/ 2 6 410 786 401 916 1 
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1 3617324 5 156 1 2 194 12 0 4849 1 75 1 0 4811 3219 75 6 . 0 000 . 0 4111 
01 0 2 4 1 9 4 3 3 5 0 
2 3618256 5 158 1 2 194 12 0 0604 1 94 1 1 0607 1700 94 6 17 0 736 8 0 4107 
01 6 0 1 1 1 9 5 6 1 5 0 1 
3 3618256 5 158 1 1 194 11 0 0604 1 94 1 1 0607 2829 94 6 8 0 736 12 0 4107 
01 7 0 2 1 1 9 5 6 1 5 0 2 1 
4 3618660 4 159 1 1 194 12 0 0606 1 92 1 2 0603 776 91 6 . 0 678 . 0 4111 
01 5 6 4 1 5 2 7 1 5 0 
5 3619275 4 162 1 1 194 12 0 0604 1 94 1 1 1500 4867 96 6 . 0 736 . 0 4107 
01 4 7 2 5 1 9 9 7 5 0 1 
6 3619275 4 162 1 2 194 11 0 0604 1 94 1 1 1500 1566 96 6 . 0 736 . 0 4104 
01 5 7 6 1 1 9 3 1 8 5 0 1 
7 1633470 5 164 1 1 194 11 0 0608 1 94 1 0 0607 2882 94 6 69 0 736 9 0 4140 
01 4 0 2 1 1 4 5 1 5 0 1 
8 1630297 4 174 1 2 194 12 0 
01 2 6 1 5 
9 1630297 4 174 1 1 194 12 0 
01 3 6 1 5 
1 1630297 4 174 1 9 194 10 0 
o 01 4 6 7 5 
1 1630297 4 174 1 1 194 10 0 
1 01 5 1 6 9 1 
0600 1 94 1 1 0607 3523 94 6 
1 5 5 3 1 
0600 1 94 1 1 0607 5112 94 6 
1 5 5 1 
0600 1 94 1 1 0607 2916 94 6 
1 5 5 0 1 
0600 1 94 1 1 0607 7450 94 6 
1 5 5 6 1 
1 3609797 5 180 1 7 193 12 2 4104 1 97 1 2 4105 8640 97 6 
2 01 2 6 3 0 9 8 9 8 
1 3610166 3 180 1 1 195 10 0 0401 2 85 1 1 0401 2646 85 6 













· 0 4100 
1 
· 0 4100 
1 
· 0 4100 
1 
· 0 4140 
1 
· 0 4104 
2 
· 0 4104 
1 
1 3618545 5 209 1 3 193 12 0 0402 1 85 1 1 0401 4025 85 6 . 0 000 . 0 4107 
4 01 9 8 1 1 3 6 9 7 5 0 1 
1 3619650 5 214 1 1 193 10 0 0401 3 85 1 1 0401 5809 85 6 13 0 620 . 0 4104 
5 04 3 1 8 7 1 3 2 3 5 0 8 5 0 1 
1 3622522 4 220 1 1 194 10 0 0401 1 85 1 1 0401 2365 85 6 . 0 620 74 0 4107 
6 01 9 0 8 7 1 3 2 3 0 0 5 0 1 
1 3622522 4 221 1 6 194 12 0 0401 1 85 1 1 0401 1399 85 6 74 0 620 79 0 4104 
7 01 0 8 2 1 3 2 3 0 0 5 0 1 
1 3623397 3 222 1 4 195 12 0 0401 2 85 1 1 0401 4260 85 6 . 0 620 . 0 4104 
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R E A C D D D D D E E E E E H H H I L M M N P P 
.0 N A A 0 R S M M M NP 0 0 0 N A D S E D 
·w R G S A Y B G T P P I S S S S C A X A X 
0 E S Y A C P Z RS P P P D T T 
n L E I T R T T R I 0 C P Z A A T 
u I G D U Y E P F T A I S D D 
.m D A S L L D Y Y P T M M F 
b R A L 
e T E R A 
r P G 
Y Y G 
P 
8 02 5 9 2 5 3 2 3 2 5 0 1 
1 3623397 3 222 1 1 195 110 0401 2 85 1 1 0401 1250 85 6 .0 620 . 0 4104 
9 02 6 9 2 1 3 2 3 2 5 0 1 
2 3624347 5 223 1 1 194 12 0 0611 2 91 1 1 0603 1117 90 6 .0 873 . 0 4104 
0 02 8 0 2 5 1 3 7 0 5 5 1 
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R E P P pp P P P P P P P P P P P P P P P P 
0 N H H P R R R R R R R R R R R R R R R 
w R Y Y LL R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 S S 0 C C C C C C C C C C C C C C C 
L I P AA C 1 1 1 1 1 1 1 2 3 4 5 6 7 8 9 
n I D A 0 1 2 3 4 5 







1 36173 75225 10 . 593 93 80 80 82 83 84 84 37 82 82 84 85 85 93 99 
2401 4247 05 51 51 04 06 31 73 10 44 22 55 55 48 61 73 01 22 
0 0 9 1 0 5 0 3 0 3 4 0 0 0 2 
2 36182 94215 15 · 537 37 93 99 93 93 93 93 93 99 99 93 
5601 7429 65 22 22 01 23 51 54 54 55 55 22 23 01 
8 8 0 3 5 5 6 3 3 6 
3 36182 94215 36 .536 36 92 99 99 
5601 7429 9 05 05 96 22 23 
0 2 8 
4 36186 33045 57 · 593 93 37 93 99 93 93 93 93 
6001 2991 0 54 54 22 01 22 51 53 54 55 
5 5 0 3 0 9 3 5 
5 36192 95304 51 · 599 99 99 
7501 4080 0 25 25 23 
4 4 2 
6 36192 99033 54 .536 36 99 99 93 99 92 93 93 93 93 93 
7501 1208 66 01 01 22 23 01 25 98 51 54 54 55 55 
2 8 0 2 0 0 3 5 5 6 
7 16334 94318 24 · 592 92 93 93 99 93 99 99 36 71 75 93 93 93 93 93 
7001 0015 48 98 98 55 55 25 04 23 35 01 02 89 01 51 53 54 54 
2 2 5 6 3 2 9 6 0 6 0 0 9 3 5 
8 16302 56896 79 · 537 37 71 93 93 93 93 99 99 
9701 1081 6 22 22 01 01 30 32 32 29 29 
0 0 7 0 5 1 2 
9 16302 56896 53 · 537 37 99 99 
9701 1081 1 22 22 29 29 
1 2 
1 16302 56896 31 · 533 33 93 93 93 93 93 99 37 99 93 93 93 99 99 36 
0 9701 1081 83 53 53 51 54 54 55 55 25 22 29 30 32 32 23 23 48 
3 3 0 3 5 5 6 5 1 7 0 5 3 2 9 
1 16302 94326 33 · 536 36 99 99 32 71 99 99 33 33 71 93 93 93 93 99 
1 9701 8944 47 12 12 29 23 02 03 25 23 51 53 01 01 30 32 32 29 
2 3 0 0 4 2 8 3 0 0 7 0 5 1 
1 36097 93042 82 .596 96 99 99 99 71 99 99 99 
2 9701 5580 6 71 71 22 29 29 01 23 23 30 
3 1 2 0 2 9 2 
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0 N H H P R R R R R R R R R R R R R R R 
w R Y Y LL R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 S S 0 C C C C C C C C C C C C C C C 
L I P AA C 1 1 1 1 1 1 1 2 3 4 5 6 7 8 9 
n I D A 0 1 2 3 4 5 







1 36101 86090 62 .536 36 93 93 93 93 99 71 71 99 93 93 93 99 99 93 
3 6601 2679 21 13 13 54 54 55 55 23 02 01 25 30 32 32 23 23 51 
3 5 5 6 1 0 0 4 7 0 5 3 2 0 
1 36185 86088 11 · 537 37 99 99 93 93 93 93 93 99 
4 4501 8560 19 22 22 22 23 51 54 54 55 55 23 
3 3 0 3 5 5 6 9 
1 36196 86090 45 .536 36 93 93 71 99 00 33 71 99 99 99 99 93 93 93 
5 5004 2679 04 15 15 55 55 02 23 56 51 01 22 29 23 23 51 54 54 
5 6 0 1 2 9 0 3 1 3 2 0 3 5 
1 36225 86090 37 · 536 36 93 93 93 00 33 33 99 99 99 71 93 93 93 93 
6 2201 2679 54 12 12 54 55 55 56 51 53 22 23 25 02 30 32 51 54 
5 5 6 2 8 3 2 2 4 0 7 0 0 3 
1 36225 86051 99 
· 537 37 93 93 93 93 99 71 99 99 93 93 93 93 93 93 
7 2201 6994 6 22 22 54 54 55 55 23 01 22 23 30 32 32 51 53 54 
3 5 5 6 2 0 2 3 7 0 5 0 9 0 
1 36233 0 
· 5 
8 9702 
1 36233 86039 17 · 536 36 93 
9 9702 4149 01 01 01 
0 
2 36243 95274 19 .599 99 71 
0 4702 1568 0 25 25 01 
5 5 0 
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R E RR S S S T T T T U V Y 
0 N E X E E T 0 0 R R N E E 
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n L 0 U E E A L P 0 I 
u I N M T Y o D S 0 




1 361732401 3 1 1560 2 49 4545 4745 0 o 696719315 10 2000 
2 361825601 4 1 1586 1 62 18371 18571 0 1 451727315 10 2000 
3 361825601 4 1 1587 1 62 28565 28665 0 1 451727315 10 2000 
4 361866001 4 1 1595 2 62 890 1346 o -2 · 10 2000 
5 361927501 4 1 1624 1 63 5277 5377 -1 o 906735317 10 2000 
6 361927501 4 1 1625 1 63 20927 21127 0 0 · 10 2000 
7 163347001 4 1 1644 1 62 5396 5496 0 1 166702315 10 2000 
8 163029701 4 1 1742 1 62 36304 36604 0 2 21703315 10 2000 
9 163029701 4 1 1743 1 62 5243 5643 -1 0 21703315 10 2000 
10 163029701 4 1 1744 1 62 38640 38640 0 0 21703315 10 2000 
11 163029701 4 1 1745 1 62 79307 79807 1 0 · 10 2000 
12 360979701 4 1 1802 2 64 8987 9487 . 941706317 10 2000 
13 361016601 4 1 1808 1 52 36784 36784 1 -1 · 10 2000 
14 361854501 4 1 2099 1 52 4769 5144 o 0 446734316 10 2000 
15 361965004 4 1 2143 1 52 67370 67937 1 0 · 10 2000 
16 362252201 4 1 2209 1 52 32550 32550 o -2 · 10 2000 
·17 362252201 4 1 2210 1 52 15505 15505 1 -1 · 10 2000 
18 362339702 4 1 2225 1 52 3860 4260 o -1 246718316 10 2000 
19 362339702 4 1 2226 1 52 1167 1267 0 -1 246966816 10 2000 
20 362434702 4 1 2238 1 62 1333 1333 -1 -1 166944315 10 2000 
150 
APPENDIX F 
MARKETSCAN DATA: OUTPATIENT SERVICE SAMPLE 
151 
Row ENROLID PROVID SVCDATE DXl DX2 DX3 DX4 DX5 PROCI 
number 
1 32001 . 02123/2000 2859 2859 
2 32001 118551932 04119/2000 41401 99213 
3 32001 946809934 07/2012000 72981 93970 
4 32001 262495705 08/08/2000 4919 99283 
5 32001 541765934 08/28/2000 4919 4919 
6 32001 675372933 09/0112000 41400 99213 
7 32001 890068434 11118/2000 4293 71010 
8 32001 890068434 11118/2000 4019 99231 
9 32001 890068434 1111912000 41401 71010 
10 32001 890068434 1111912000 41090 93010 
11 32001 890068434 1111912000 41400 99232 
12 32001 890068434 11/19/2000 41400 99232 
13 32001 890068434 11119/2000 41400 99232 
14 32001 890068434 11119/2000 41090 99233 
15 32001 890068434 11120/2000 41400 93010 
16 32001 890068434 1112112000 41400 93010 
17 32001 890068434 11121/20004271 93510 
18 32001 890068434 1112112000 4271 93539 
19 32001 890068434 1112112000 4271 93540 
20 32001 890068434 11/21/2000 4271 93545 
21 32001 890068434 1112112000 4271 93556 
22 32001 890068434 11122/2000 41401 92980 
23 32001 890068434 11122/2000 41400 93010 
24 32001 890068434 1112212000 410 11 93307 
25 32001 890068434 11/22/2000 41011 93320 
26 32001 890068434 11122/2000 41011 93325 
27 32001 890068434 11123/2000 41400 93010 
28 32001 890068434 11127/2000 41401 71020 
29 32001 890068434 1112712000 4271 93620 
30 32001 890068434 11130/2000 4271 33249 
31 32001 890068434 11/3012000 4271 93641 
32 42601 569732410 08/0912000 8830 99203 
33 42601 569732410 08/09/2000 8830 11885 
152 
APPENDIX G 
SAS PROGRAM TO EXTRACT INPATIENT ADMISSION SAMPLE 
153 
LlBNAME MYDATA 'H:\Data Mining\Fall 2011\Data'; 
LlBNAME MS 'H:\MSdata'; 
%MACRO NAMES(NAME= , NUMBER= ); 




/* EXTRACT AMI OBSERVATION FROM INPATIENT ADMISSION TABLES */ 
DATA IN1; 
SET MS.INPATIENTADMISSIONO; 
LENGTH EPISODE 3.; 
EPISODE = 3; 
IF MISSING(ENROLlD) = 0 THEN 
DO; 
IF SUBSTRN(DX1, 1,3) = '410' THEN 
IF LENGTH(DX1) = 5 THEN EPISODE = 
SUBSTRN(DX1 ,5,1); 
ELSE EPISODE = 0; 
ELSE IF SUBSTRN(DX2,1,3) = '410' THEN 
IF LENGTH(DX2) = 5 THEN EPISODE = 
SUBSTRN(DX2,5,1 ); 
ELSE EPISODE = 0; 
END; 




LENGTH EPISODE 3.; 
EPISODE = 3; 
IF MISSING(ENROLlD) = 0 THEN 
DO; 
IF SUBSTRN(DX1,1,3) = '410' THEN 
IF LENGTH(DX1) = 5 THEN EPISODE = 
SUBSTRN(DX1 ,5,1); 
ELSE EPISODE = 0; 
ELSE IF SUBSTRN(DX2,1,3) = '410' THEN 
IF LENGTH(DX2) = 5 THEN EPISODE = 
SUBSTRN(DX2,5,1 ); 
ELSE EPISODE = 0; 
END; 
IF EPISODE NE 3; 
RUN; 
154 
/* COLLECT SMALLER SUBSETS (ABOVE) INTO ONE LARGE SET OF 




/* CREATE MASTER TABLE OF UNIQUE ENROLlD'S */ 
DATA INP _MT; 
SET MYDATA.INALL (KEEP= ENROll D); 
RUN; 





SAS PROGRAM TO COMPUTE INPATIENT SAMPLE SUMMARY STATISTICS 
156 












VAR AGE DAYS TOTPAY; 
ODS GRAPHICS ON; 
TITLE; 
TITLE1 "Summary Statistics"; 
TITLE2 "Box and Whisker Plots"; 
PROC SGPLOT DATA= MYDATAINALL; 
VBOXAGE; 
RUN;QUIT; 
PROC SGPLOT DATA= MYDATAINALL; 
VBOX DAYS; 
RUN;QUIT; 
PROC SGPLOT DATA= MYDATA.INALL; 
VBOX TOTPAY; 
RUN;QUIT; 
ODS GRAPHICS OFF; 
157 
APPENDIX I 
SAS PROGRAM TO EXTRACT OUTPATIENT RECORDS 
158 
LlBNAME MYDATA 'H:\Data Mining\Fall 2011\Data'; 
LlBNAME MS 'H:\MSdata'; 
/* FOR TABLE CORRESPONDING TO 2001 */ 
%MACRO NAMES(NAME= , NUMBER= ); 
%00 N=1 % TO &NUMBER; 
&NAME&N (DROP = WGTKEY) 
%END; 
%MEND NAMES; 
/* FOR TABLE CORRESPONDING TO 2000 *j 
%MACRO NAMES1 (NAME= , NUMBER= ); 
%00 N=1 % TO &NUMBER; 




/* GET OUTPATIENT SERVICE OBSERVATION CORRESPONDING TO *j 
/* MASTER TABLE ENROLID VARIABLE *j 
%MACRO GET_OUTPAT_SVC(NAME1=, NAME2=, NAME3=, NUMBER=); 
%00 N=1 % TO &NUMBER; 




MERGE &NAME1 &N (IN=LEFT) &NAME2 (IN=RIGHT); 
BY ENROLlD; 
IF LEFT AND RIGHT; 
RUN; 
%END; 
/* CREATE A SINGLE OUTPATIENT SERVICE TABLE *j 
%GET_OUTPA T_SVC(NAME1 =MS.OUTPATIENTSERVICEO, 
NAME2=MYDAT A. MASTER_ TABLE, NAME3=OUTO, NUMBER=6); 
%GET_OUTPAT_SVC(NAME1=MS.OUTPATIENTSERVICE1,NAME2=MYDAT 







SET MYDATA.OUTALL (KEEP=ENROLID SVCDATE PROVID DX1-DX5 
PROC1); 
RUN; 
PROC SORT DATA=OUTSAMPLE; 
BY ENROLID SVCDATE PROVID; 
RUN; 
/* TRANSFORM SET FROM WIDE TO LONG */ 
DATAOS1; 

























SET OUTSAMPLE (KEEP=ENROLID SVCDATE PROVID PROC1); 
RUN; 
DATAOUT1; 
SET OS1 OS2 OS3 OS4 OS5; 
RUN; 
160 
PROC SORT DAT A=OUT1 ; 
BY ENROLID SVCDATE PROVID; 
RUN; 
/* TRANSFORM SET FROM LONG TO WIDE */ 
PROC TRANSPOSE DATA=OUT1 OUT=TRANS1 (DROP=_NAME __ LABEL_) 
PREFIX=DX; 
VAR DX; 
BY ENROLID SVCDATE PROVID; 
RUN; 
PROC TRANSPOSE DATA=OS6 OUT=TRANS2 (DROP= _NAME __ LABEL_) 
PREFIX=PROC ; 
VAR PROC1; 
BY ENROLID SVCDATE PROVID; 
RUN; 
PROC SORT DA T A=TRANS 1 ; 
BY ENROLID SVCDATE PROVID; 
RUN; 
PROC SORT DA T A=TRANS2; 




MERGE TRANS1 (IN=LEFT) TRANS2 (IN=RIGHT); 
BY ENROLID SVCDATE PROVID; 
IF LEFT AND RIGHT; 
DATA OUT_VISIT _BEFORE OUT_VISIT _AFTER; 
SET MYDATA.OUT_BY_ID_DATE; 
IF SVCDATE < ADMDATE THEN 
OUTPUT OUT_VISIT _BEFORE; 
ELSE 
OUTPUT OUT_VISIT _AFTER; 
RUN; 
PROC FREQ DATA=OUT _VISIT_BEFORE; 
TABLES ENROLlD; 
RUN; 





SAS PROGRAM DATA DERIVATION 
162 
/* OUTPUT: FIRST OBSERVATION (EVENT) FROM INPATIENT ADMISSION */ 
/* VAR REINFARCTION: 1 IF THERE IS A SECOND AMI OBSERVATION 
CORRESPONDING TO THE SAME ENROLID */ 
/* a IF THERE IS ONLY ONE OBSERVATION FOR THE CORRESPONDING 
ENORLID */ 
PROC SORT DATA=MYDATAINALL (KEEP=ENROLID ADMDATE) 
OUT=SORT _INALL; 
BY ENROLID ADMDATE; 
RUN; 
DATA MYDATAREINFARCTION_INALL; 
SET SORT _INALL; 
RUN; 
BY ENROLlD; 
LENGTH REINFARCTION 3; 
IF FIRST.ENROLID = 1 AND LAST.ENROLID = 1 THEN 
DO; 
END; 
REINFARCTION = 0; 
OUTPUT; 
ELSE IF FIRST.ENROLID = 1 AND LAST.ENROLID = 0 THEN 
DO; 
END; 
REINFARCTION = 1; 
OUTPUT; 
/* OUTPUT: NUMBER OF DAYS BETWEEN FIRST ADMISSION AND 
READMISSION */ 
PROC SORT DATA=MYDATAINALL_SURV (KEEP=ENROLID ADMDATE 
LASTIN NEXTIN) OUT=SORT _INALLSURV; 
BY ENROLID ADMDATE; 
RUN; 
DATA MYDATAINALL_SURV_LOH; 
SET SORT _INALLSURV; 
LENGTH LOH 3; 
BY ENROLlD; 
IF FIRST.ENROLID = 1 THEN 
DO; 




%MACRO OBTAINDRUGNAME(INTABLE, NAMETABLE, BYVARIABLE, 
OUTTABLE); 
163 
PROC SORT DATA=&INTABLE; 
BY &BYVARIABLE; 
RUN; 




MERGE &INTABLE (IN = LEFT) &NAMETABLE (KEEP = NDC 
PROPRIETARYNAME SUBSTANCENAME); 
BY &BYVARIABLE; 




LENGTH NAME $ 99; 
IF MISSING(SUBSTANCENAME) = 0 THEN 
NAME = SUBSTANCENAME; 
ELSE 
NAME = PROPRIETARYNAME; 
DROP PROPRIETARYNAME SUBSTANCENAME; 
RUN; 
%MEND; 




PROC SORT DATA=MYDAT A.AMI_PAT _RXRECORDS OUT=RXRECORDS; 
BY ENROLlD; 
RUN; 
/*CREATE TABLE OF ALL RX RECORDS FOR AMI PATIENTS WITH THE 
DATE OF THE EVENT: FIRST AMI *j 
DATA MYDATA.RXRECORD_EVENTDATE; 
RUN; 
MERGE RXRECORDS SORT _REINFARCTION; 
BY ENROLlD; 
/* OUTPUT: PRESCRIPTION DOCUMENTS *j 
164 
DATA RX_BEFORE RX_AFTER; 
SET MYDATARXRECORD_EVENTDATE (KEEP = ENROLID NDCNUM 
SVCDATE ADMDATE); 






SET RX_BEFORE (KEEP=ENROLID NDCNUM); 
LENGTH NDC $ 9; 




SET RX_AFTER (KEEP=ENROLID NDCNUM); 
LENGTH NDC $ 9; 
NDC = SUBSTR(NDCNUM,1 ,9); 
DROP NDCNUM; 
RUN; 
%OBTAINDRUGNAME(RX_BEFORE_NDC, MYDATANDCOLD, NDC, 
RX_BEFORE_NAME); 
%OBTAINDRUGNAME(RX_AFTER_NDC, MYDATANDCOLD, NDC, 
RX_AFTER_NAME); 
/* TRANSPOSE PRESCRIPTIONS: EACH PATIENT HAS ONE ROW WITH 
MANY PRESCRIPTIONS *j 
PROC SORT DATA=RX_BEFORE_NAME; 
BY ENROLlD; 
RUN; 
PROC SORT DATA=RX_AFTER_NAME; 
BY ENROLlD; 
RUN; 













LENGTH NEWNAME $ 99; 
LENGTH PX $ 2000; 
ARRAY P _X[*] NAME:; 
PX = TRANSLATE(LEFT(TRIM(P _X[1])),'_', "); 
DO 1=2 TO DIM(P _X); 
END; 
NEWNAME = TRANSLATE(LEFT(TRIMN(P _X[I])), '_', "); 
PX = CATX(' I, PX, NEWNAME); 




LENGTH NEWNAME $ 99; 
LENGTH PX $ 2000; 
ARRAY P _X[*] NAME:; 
PX = TRANSLATE(LEFT(TRIM(P _X[1])),'_', I '); 
DO 1=2 TO DIM(P _X); 
END; 
NEWNAME = TRANSLATE(LEFT(TRIMN(P _X[I])) , '_', "); 
PX = CATX(' I, PX, NEWNAME); 
KEEP ENROLID PX; 
RUN; 
/* OUTPUT: PRESCRIPTION COUNTS *j 
DATA BEFORE_EVENT AFTER_EVENT; 
SET MYDATARXRECORD_EVENTDATE (KEEP=ENROLID SVCDATE 
ADMDATE NDCNUM); 
LENGTH NDC $ 9; 
RUN; 
NDC = SUBSTR(NDCNUM,1 ,9); 





PROC SORT DATA=BEFORE_EVENT (DROP=NDCNUM) 
OUT=BEFORE_EVENT _COMP NODUPKEY; 
BY ENROLID NDC; 
RUN; 
PROC SORT DATA=AFTER_EVENT (DROP=NDCNUM) 
OUT=AFTER_EVENT _COMP NODUPKEY; 
BY ENROLID NDC; 
RUN; 
/* CREATE INPATIENT DIAGNOSIS STRING */ 
PROC SORT DATA=MYDATA.INALL (KEEP=ENROLID ADMDATE DX1-DX15) 
OUT=IN_OBS; 





IF FIRST.ENROLID = 1 THEN OUTPUT; 
RUN; 
DATA MYDATA.IN_DX_STRING; 
SET FIRST _IN_ADM; 
LENGTH DXT $ 80; 
ARRAY DX[*] DX1-DX15; 
DXT = TRIM(DX[1]); 
DO 1=2 TO 15; 
DXT = TRIM(CATX(' " DXT, DX[I])); 
END; 
KEEP ENROLID DXT; 
RUN; 




PROC SORT DATA=MYDATA.OUT_BY_ID_DATE (KEEP=ENROLID 
SVCDATE) OUT=SORT _OUT; 
BY ENROLlD; 
RUN; 
I*CREATE TABLE OF ALL OUTPATIENT VISITS WITH THE DATE OF THE 
EVENT: FIRST AMI */ 
167 
RUN; 
MERGE SORT_OUT SORT _REINFARCTION; 
BY ENROLlD; 
DATA OUT_VISIT_BEFORE OUT_VISIT_AFTER; 
SET OUT_WITH_ADMDATE; 
IF SVCDATE < ADMDATE THEN 
OUTPUT OUT_VISIT _BEFORE; 
ELSE 
OUTPUT OUT_VISIT _AFTER; 
RUN; 
1* WIDE TO LONG FORMAT -- PCI CABG THROMBOLYTIC THERAPY ONLY 
*/ 
DATA TMP1 (KEEP=ID PR TRT); 
SET MYDATA.ALL (KEEP=ENROLID PROC1-PROC15 TRT 
WHERE=(TRT NOT = 0)); 
ARRAY PRC [15] PROC1-PROC15; 
DO 1=1 TO 15; 





ID = ENROLlD; 
PR = PRC[I]; 
OUTPUT; 
1* SEPARATE ICD9 RECORDS FROM CPT RECORDS */ 
DATA ICD CP; 
SET TMP1; 
RUN; 




1* FILTER TO VALID CPT CODES */ 
PROC SORT DATA=MYDATA.CPT; 
BY CODE; 
RUN; 





MERGE CP (IN=LEFT) MYDATA.CPT (KEEP=CODE IN=RIGHT 
RENAME=(CODE=PR)); 
BYPR; 
IF LEFT AND RIGHT; 
RUN; 
/* GET DISCHARGE STATUS */ 
DATA TMP3 (KEEP=ID PR TRT); 
SET MYDATA.ALL (KEEP=ENROLID ALIVE TRT 
RENAME=(ENROLlD=ID) WHERE=(TRT NOT = 0)); 
PR = PUT(ALlVE, $5.); 
RUN; 
/* APPEND ICD9 TO CPT */ 
DATATMP4; 
SET TMP2 ICD; 
RUN; 
/* APPEND DISCHARGE STATUS */ 
DATA TMP5; 
SET TMP4 TMP3; 
RUN; 





SAS PROGRAM - REGRESSION AND SURVIVAL ANALYSIS 
170 
DATA OUT_VISITS; 
SET MYDATA.ALL (KEEP=ENROLID ADMDATE AGE DAYS ALIVE TRT 
VISITS_BEFORE VISITS_AFTER REGION SEX INDSTRY); 
MONTHS = INTCK(,MONTH', ADMDATE,'31DEC2001'D, 'C'); 
LOGRISK = LOG(MONTHS/24 + .5); 
VISITS_PER_MONTH = VISITS_AFTER/(MONTHS + .5); 
LABEL VISITS_PER_MONTH = 'VISITS PER MONTH' 
VISITS_AFTER = 'No. OF VISITS'; 
OBS+1; 







SET MYDATA.ALL (KEEP=ENROLID ADMDATE AGE DAYS ALIVE TRT 
RX_CNT_B RX_CNT_A REGION SEX INDSTRY 
RENAME=(RX_CNT_A=PRESCRIPTION_COUNT)); 
MONTHS = INTCK(,MONTH', ADMDATE, '31DEC2001'D, 'e'); 
LOGRISK = LOG(MONTHS/24 + .5); 
Rx_COUNT_PER_MONTH = PRESCRIPTION_COUNT/(MONTHS + .5); 
LABEL Rx_COUNT _PER_MONTH = 'Rx PER MONTH' 
PRESCRIPTION_COUNT = 'No. OF Rx'; 
OBS+1; 




WHERE ALIVE = 1; 
RUN; 
PROC GENMOD DATA=OUT_VISITS PLOTS=(PREDICTED); 
TITLE1 'OUT VISITS PER MONTH'; 
CLASS TRT INDSTRY REGION SEX; 
MODEL VISITS_AFTER = AGE DAYS TRT REGION SEX INDSTRY I 
DIST=POISSON OFFSET=LOGRISK TYPE3; 
RUN; 
PROC GENMOD DATA=OUT_VISITS PLOTS=(PREDICTED); 
TITLE1 'OUT VISITS PER MONTH ADJUSTED'; 
CLASS TRT INDSTRY REGION SEX; 
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MODEL VISITS AFTER = AGE DAYS TRT REGION SEX INDSTRY / 
DIST=POISSON OFFSET=LOGRISK SCALE=PEARSON TYPE3; 
OUTPUT OUT=SASDATA.VISITS PREDICTED=PRED; 
RUN; 
PROC GENMOD DATA=RX_COUNT PLOTS=(PREDICTED); 
TITLE1 'RX COUNT PER MONTH'; 
CLASS TRT INDSTRY REGION SEX; 
MODEL PRESCRIPTION_COUNT = AGE DAYS TRT REGION SEX 
INDSTRY / DIST=POISSON OFFSET=LOGRISK TYPE3; 
RUN; 
PROC GENMOD DATA=RX_COUNT PLOTS=(PREDICTED); 
TITLE1 'RX COUNT PER MONTH ADJUSTED'; 
CLASS TRT INDSTRY REGION SEX; 
MODEL PRESCRIPTION COUNT = AGE DAYS TRT REGION SEX 
INDSTRY / DIST=POISSON OFFSET=LOGRISK SCALE=PEARSON TYPE3; 






3='THROMBOL YTIC THERAPY'; 
RUN; 
DATA SURVDATA; 
SET MYDATA.ALL (KEEP=ENROLID LOH REINFARCTION AGE SEX 
TRT REGION ALIVE DAYS WHERE=(TRT NOT = 0)); 
FORMAT TRT TRT.; 
LABEL LOH = 'SURV. DAYS'; 
RUN; 
PROC PHREG DATA=SURVDATA; 
CLASS REGION SEX TRT; 
MODEL LOH*REINFARCTION(O) = TRT AGE SEX REGION DAYS/ 
TIES=EFRON; 
TITLE1 'ORIGINAL SET'; 
RUN; 
PROC PH REG DATA=SURVDATA; 
MODEL LOH*REINFARCTION(O) = TRT I TIES=EFRON; 
STRATA TRT; 
BASELINE OUT=A LOGLOGS=LLS SURVIVAL=S; 
TITLE1 'STRATIFIED SET'; 
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RUN; 
PROC GPLOT DATA=A; 
PLOT S*LOH=TRT; 
RUN; 
SYMBOL 1 INTERPOL=JOIN COLOR=BLACK LlNE=1; 
SYMBOL2 INTERPOL=JOIN COLOR=BLUE LlNE=2; 
SYMBOL3 INTERPOL=JOIN COLOR=GREEN LlNE=3; 
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